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OBMBRAL INTRODUCTION 
Dlsoovary of ADP-rlboaylatlon réactions 
ADP-ribosylation is a novel type of reversible covalent 
posttranslational modification of proteins in which the ADP-
rlbose moiety of NAD+ is transferred to specific amino acid 
residues in proteins. These reactions are ubicpiitously 
distributed in nature and are Implicated in the regulation 
of cell proliferation (1), protein synthesis (2), signal 
transduction (3), calcium mobilization (4), and modulation 
of activities of certain enzymes (5-8). 
ADP-ribosylation reactions were discovered in 1968 when 
it was demonstrated by Nishizuka et al. (9) that the 
chromâtin-associated enzyme, poly(ADP-rlbose) synthetase, 
catalyzed the transfer of the ADP-rlbose moiety of NAD+ to 
hlstones and other nuclear proteins. These reactions are 
known as poly(ADP-rlbosyl)ation reactions because the 
product contains successive transfer of the ADP-rlbose units 
resulting in the formation of a homopolymer with repeating 
ADP-rlbose units. 
At about the same time it was demonstrated by Honjo et 
al. (2) that in the presence of diphtheria toxin, ADP-rlbose 
moiety of NAD+ was transferred and covalently attached to 
elongation factor 2 (EF-2) obtained from rat liver. 
In 1969, it was discovered by Honjo et al. (10,11) that, in 
contrast to the nuclear enzyme system, a single unit of ADP-
ribose moiety was transferred to EF-2 by diphtheria toxin. 
These observations constitute the first example of mono(ADP-
ribosyl)ation reactions. 
Mono(ADP-ribosyl)ation predominates by far (> ten-fold) 
over poly(ADP-ribosyl)ation in mammalian cells, particularly 
in the extranuclear compartments (12). Mono(ADP-
ribosyl) ation reactions are catalyzed by viral (13-16), 
prokaryotic (Table I) (2,10,17-23) and eukaryotic enzyme 
systems (Table II) (24-31). A number of bacterial strains 
produce mono(ADP-ribosyl)transferases as components of 
toxins which are secreted. These enzymes ADP-ribosylate 
components of eukaryotic cells (2,10,17-19,22,23,32). 
According to the amino acids that accomodate ADP-
ribosylation, enzymatic mono(ADP-ribosyl)ation reactions are 
classified into five subtypes: diphthamide-, 
arginine-, asparagine-, and cysteine-specific ADP- , 
ribosylation. Formation of a nonenzymatic adduct with 
lysine, arginine, and histidine has also been observed. 
Poly(ADP-ribosyl)ation reactions are involved in the 
regulation of cell proliferation, differentiation, and DNA 
repair (1,33,34). Bacterial toxins possessing mono(ADP-
ribosyl )transferase activity exert their toxicity by 
Tmbl# I 
Prokaryotlo mono(ADP-rlboayl)trmnmf#rmm## 
Prokaryotss Protein(a) modified Amino moid 
Diphtheria toxin EF-2 diphthamide 
Cholera toxin stimulatory 6-protein, Gsa 
transducin (Ta) 
arginlne 
Pertussis toxin inhibitory 6-protein, Gia 
transducin (Ta) 
cysteine 
Botulinum toxins 
Type and D 
Type Cg 
Type C3 
rha protein 
actln 
rac proteins 
asparaglne 
arginlne 
? 
£• ÇQll 
enterotoxin 
stimulatory G-proteln, Gsa? arginlne 
Pseudomonas 
a?rMqin<?9a 
EF-2 diphthamide 
PhpapspiriiitAîB dinltrogenase reductase arginlne 
T4 phage alt 
protein 
£. coll RNA polymerase arginlne 
T4 phage rood 
protein 
£. coll RNA polymerase arginlne 
N4 phage £. coll proteins arginlne 
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Tabic II 
Eukaryetle mono(ADP-ribomyl)transfarasas 
Bukaryotas Protein(s) modified Amino aoid 
Rat liver 
mitochondria 
mitochondrial 
proteins 
arginine 
Turkey 
erythrocytes 
erythrocyte 
proteins 
arginine 
Hen liver nuclei ? arginine 
Rabbit skeletal 
muscle 
? arginine 
Human erythrocytes erythrocyte 
proteins 
arginine 
Human erythrocytes ? cysteine 
Mammalian enzyme EF-2 diphthamide 
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ADP-rlbosylatlng eukaryotic proteins involved in protein 
synthesis and signal transduction via GTP-binding proteins 
(2,3). ADP-ribosylation may also play a vital role in 
regulation of certain metabolic processes. In the 
photosynthetic bacteria, Rhodosoirilium cabmm, the 
nitrogenase activity of dinitrogenase reductase is regulated 
by reversible ADP-ribosylation (5,6). The function of 
mono(ADP-ribosyl)ation reactions catalyzed by eukaryotic 
ADP-ribosyltransferases is unknown. 
Prokaryotio mono(ADP-ribosyl)transferases 
Diphtheria, a dreaded disease that killed up to 50% of 
the infected people until the late 19th century, results 
from infection with toxin producing strains of 
Corvnebacterium diphtheriae (2,10). These strains produce a 
potent exotoxin which is disseminated throughout the host 
following colonization of mucous membranes by the organism. 
The toxin inhibits protein synthesis in affected tissues 
eventually resulting in necrosis of various organs. 
Diphtheria toxin is synthesized as a single polypeptide 
chain which is processed upon secretion to a protein with a 
molecular weight of approximately 62,000 daltons (35). 
Enzymatic cleavage and chemical reduction produce two 
fragments, A and B, with molecular weights of 21,000 and 
40,000 daltons, respectively (36). Fragment A, the N-
terminal fragment, is responsible for the enzymatic 
properties of the toxin (14,37). Fragment B, the C-terminal 
fragment, is involved in attachment and entry of the toxin 
into the target cell. The toxin then ADP-ribosylates EF-2 
(10,11). EF-2 is a protein component required for 
polypeptide chain elongation on ribosomes in eukaryotic 
cells. AOP-ribosylation of this protein results in 
inhibition of protein synthesis (11). The target amino acid 
for ADP-ribosylation by diphtheria toxin in EF-2 is a 
modified histidine residue, diphthamide (38). 
Cholera toxin is an arginine-specific mono(ADP-
ribosyl)transferase produced by the bacteria. Vibrio 
cholerae (39). The disease, cholera, caused by the bacteria 
is characterized by watery diarrhea which leads to 
dehydration and metabolic acidosis of the affected 
individual. The toxin binds to receptors on intestinal 
mucosal cells and stimulates adenylate cyclase activity 
(40,41). The rise in cAMP then leads to diarrhea and the 
accompanying chloride and fluid losses. 
Cholera toxin is an oligomeric protein consisting of 
two types of subunits: a single "heavy" subunit (A-subunit) 
of Mr 28,000 and an aggregate of five "light" subunits 
(B-subunits) of Mr 11,000 each (42). The B-subunlts form a 
ring of tight, noncovalent bonds. The A-subunit is linked 
to and partially inserted in the B-ring through weaker 
noncovalent interactions. The A-subunit is comprised of two 
fragments linked by a disulfide bond. The two fragments, A1 
(Mr 21,000) and A2 (Mr 7,000) can be separated by treatment 
with thiol reducing agents (43). The B-subunit binds to the 
cell surface by specific interaction with the 
monosialoganglioside (6M1) and the A-subunit is passed 
through the plasma membrane and the A1 fragment, possessing 
enzyme activity, is released from the 2A-5B complex upon 
reduction by a thiol reducing agent. 
Among the most widely known proteins ADP-ribosylated by 
cholera toxin are the guanine nucleotide-binding regulatory 
proteins (19,44,45). ADP-ribosylation of the a-subunit of 
the regulatory stimulatory 6-protein, 6s, inhibits the 
intrinsic GTPase activity and concomitantly activates 
adenylate cyclase (19). This results in increased levels of 
CAMP. ADP-ribosylation of the a-subunit of transducin, a 
GTP-binding regulatory protein found in the bovine retinal 
rod outer segment mediating the signal coupling between 
rhodopsin and cGMP phosphodiesterase, by cholera toxin 
results in loss of light-activated cGMP phosphodiesterase 
activity (32). Cholera toxin also catalyzes 
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auto-ADP(ribosyl)ation of its A1 peptide (46). The 
significance of this auto(ADP-ribosyl)ation activity is not 
understood. 
Pertussis toxin was first investigated as a secretory 
product of Bordalla nartusaia. the pathogenic bacterium 
causing whooping cough (47). Pertussis toxin, also known as 
an islet activating protein (lAP), is a cysteine-specific 
ADP-ribosyltransferase which causes activation of pancreatic 
islet cells (21). This toxin exerts its effects on cells by 
catalyzing the ADP-ribosylation of G-proteins, transducin 
(48) and the inhibitory regulatory subunit (6i) of adenylate 
cyclase (49). Like cholera toxin, pertussis toxin also 
requires reductive cleavage of disulfide bonds in the A-
prbtomer to display ADP-ribosyltransferase.and 
glycohydrolase activity (50). 
Pertussis toxin-catalyzed ADP-ribosylation of the o-
subunit of the inhibitory regulatory G-protein, 6i, 
interferes with the ability of inhibitory agonists to 
decrease adenylate cyclase activity resulting in 
intracellular cAMP accumulation. ADP-ribosylation of the a-
subunit of transducin (Ta) at a cysteine residue has been 
shown to exhibit decreased affinity for the rod outer 
segment membranes (48). Pertussis toxin preferentially 
modifies the inactive species of transducin and stabilizes 
9 
it in that state, accounting for the loss of light-activated 
cGMP phosphodiesterase activity in rod outer segments. 
Although both cholera and pertussis toxin inhibit 6TP 
hydrolysis, they appear to do so by different mechanisms. 
Pertussis toxin-catalyzed ADP-ribosylation impairs the 
exchange of 6TP for GDP on Ta, whereas cholera toxin-
catalyzed ADP-ribosylation inhibits intrinsic GTPase 
activity of Ta. 
The most recently discovered toxins possessing ADP-
ribosyltransferase activity are the botulinum toxins 
(22,23). Type and type D toxins are produced by an 
anaerobic organism, Clostridium botulinum. Type Cg and C3 
toxins, possessing ADP-ribosyltransferase activity, are 
produced by certain strains of Clostridium botulinum type C 
(51,52). Botulinum toxins are potent neurotoxins which act 
at presynaptic terminals of cholinergic as well as other 
neurons and block the release of neurotransmitters. 
Although the exact mechanism of this inhibition has not yet 
been clarified, a three-step model has been proposed to 
account of their actions (53). The first step is the 
binding of toxins to receptors on the plasma membrane of 
target cells, and the second step is internalization where 
they enter the cells possibly via receptor-mediated 
endocytosis. Finally, poisoning occurs where they damage 
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release function of the cells. The mechanism of 
intracellular poisoning remains to be elucidated. 
Botulinum toxins also consist of light and heavy chains 
bound by an interchain disulfide bond and toxic activity 
resides solely in the light chain (54). Botulinum toxins 
have been shown to ADP-ribosylate 21,000-26,000 dalton 
eukaryotic GTP-binding proteins (55-57). A ras-related rho 
protein (Mr 21,000), predominantly found in neural tissues, 
has been shown to be ADP-ribosylated at a specific 
asparaginyl residue by botulinum type and type D toxins 
(58). The rac proteins•(racl and rac2l. a novel class of 
human rag-related family of proteins that are 58% homologous 
with the rho protein, are ADP-ribosylated by botulinum C3 
ADP-ribosyltransferase (59). The 21,000 dalton proteins are 
involved in cell growth and transformation (60). Botulinum 
C2 toxin ADP-ribosylates actin at a specific arginyl residue 
(61). The significance of ADP-ribosylation of the low-
molecular-weight GTP-binding proteins by these toxins is not 
yet understood. 
Eukaryotic mono(ADP-ribosyl)transferases 
Many animal cells possess endogenous mono(ADP-
ribosyl) transferase activities which modify specific protein 
substrates (24-31,62). The activity has been detected in 
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turkey erythrocytes (25), rat liver (63), Xenonua laevla 
liver, lung, muscle, heart and erythrocytes (29), bovine 
thyroid (30), bovine, porcine, and rabbit skeletal muscle 
(31) and various other tissues listed in Table II. Most 
purified ADP-ribosyltransferases described catalyze the 
formation of N-glycosidic bonds between ADP-ribose and 
arginine in vitro. A diphthamide-specific ADP-
ribosyltransferase has also been identified in mammalian 
system (27). Recently, a cysteine-specific ADP-
ribosyltransferase was detected in human erythrocytes (63). 
The physiological function of these cellular ADP-
ribosyltransferases is not known at present. One 
possibility is the regulation of signal transduction in the 
adenylate cyclase system or any other enzyme system 
involving G-proteins. An ADP-ribosyltransferase from turkey 
erythrocytes has been shown to ADP-ribosylate the a-subunit 
of the inhibitory regulatory 6-protein, 6ia (25). The role 
of G-proteins has been demonstrated not only in the hormonal 
stimulation or inhibition of adenylate cyclase activity but 
also, more recently, in effects not linked to adenylate 
cyclase. G-proteins have been Implicated in K+ channel 
activity (64), Na+/H+ exchange (65), phosphoinositide 
metabolism (66,67), receptor-mediated Ca^ + mobilization 
(66,67), and activation of cGMP-dependent 
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phosphodiesterase (68). Another possibility in function may 
be the "fine tuning" of protein synthesis at the level of 
elongation factor-2 (27). Yet another function may be the 
regulation of Ca^ + release from mitochondria (4). 
There is also some evidence that ADP-ribosylation may 
have some effect on phosphorylation. Studies by Tanigawa et 
al. (7) and Tsuchiya et al. (8) have shown that ADP-
ribosylation of histone (7) and phosphorylase kinase (8) by 
hen liver nuclei ADP-ribosyltransferase suppresses 
subsequent phosphorylation by cANP-dependent protein kinase. 
We also observed a similar effect using a model substrate 
(Leu-Arg-Arg-Ala-Ser-Leu-Gly) (69). ADP-ribosylation of the 
arginyl residues suppressed subsequent phosphorylation by 
cAMP-dependent protein kinase and phosphorylation of this 
peptide also decreased the extent of ADP-ribosylation by 
cholera toxin. 
Endogenous ADP-ribosyltransferases have been shown to 
exist in various cell compartments. Four ADP-
ribosyl transferases (A,B,C, and D) have been identified in 
turkey erythrocytes (70). They differ in their 
physiochemical properties, substrate specificities, and 
localization. Transferase A was purified from the 100,000xg 
supernatant fraction of turkey erythrocytes. This protein 
has a Mr 28,000. The enzyme is stabilized by propylene 
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glycol and NaCl. The activity of this purified enzyme is 
increased more than ten-fold by inorganic salts and is also 
stimulated by hlstones. Transferase B, also from turkey 
erythrocytes, differs from transferase A in many ways. It 
has a Mr 32,000, is inhibited about 40% by chaotropic salts, 
and is not affected by histones. There are also differences 
between transferase A and B with respect to substrate 
specificity. Transferase B uses only NAD as substrate, 
whereas transferase A uses both NAD+ and NADP+. 
Transferases C and D have recently been identified as 
membrane-associated (transferase C) and nuclear (transferase 
D) enzymes in turkey erythrocytes. Their molecular weights 
are similar to those of enzymes A and B. Transferase C is 
slightly stimulated by salt and histones and transferase D 
is stimulated more than ten-fold by histones or salt. The 
differences may reflect different functions of the enzymes. 
We have also found an arginine-specific ADP-
ribosyltransferase activity in the nucleus, the cytoplasm, 
and in the membrane of primary chick myoblast cultures. The 
specificity of ADP-rlbosylation catalyzed by the cellular 
ADP-ribosyltransferases in various cell compartments 
supports the contention that these enzymes play significant 
roles in vivo. 
14 
Ch«mlstry of th# bond 
Poly(ADP-ribosyl)ation reactions occur via ester 
linkages to the C-carboxyl group of glutamic acid residue 
and to the a-carboxyl group of terminal lysine residues (0-
glycosidic linkages) (71). In the case of most viral and 
bacterial mono(ADP-ribosyl)transferases the acceptor 
proteins for ADP-ribose have been clearly identified, often 
including the amino acid residue diphthamide, arginine, and 
cysteine serving as the site of modification (25,27,48). 
The bond formed by diphtheria, botulinum, and cholera toxin 
between diphthamide and ADP-ribose, asparagine and ADP-
ribose, and between arginine and ADP-ribose, respectively, 
is an N-glycosidic linkage (25,27). Pertussis toxin 
attaches the ADP-ribose group on the -SH group of cysteine 
residue In proteins (48). 
In addition to these enzymatic ADP-ribosyltransferase 
reactions, ADP-rlbose-acceptor adducts can result from a 
nonenzymatlc reaction between free ADP-rlbose and certain 
acceptor sites, e.g., by Schlff base formation at lysine, 
arginine, or hlstldlne residues (72). These reactions 
require fairly long incubation, relatively high 
concentrations of reactants, and occur best at alkaline pH 
(72). Nonenzymatlc reactions have been shown to occur in 
submltochondrlal particles from rat liver 
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mitochondria (73), from beef heart (74), and in rat liver 
plasma membranes (73,74). 
Hydroxylamine stability has been used to classify (ADP-
ribosyl)protein linkages into sensitive and resistant 
linkages. The polymer-protein linkages formed via poly(ADP-
ribosyl)ation reactions are very sensitive to neutral 
hydroxylamine (71) and alkaline pH. The ADP-ribose-
diphthamide bond is alkali-stable and is also stable to 
hydroxylamine (75). the linkage between cysteine and ADP-
ribose is remarkably resistant to cleavage with neutral 
hydroxylamine (76). The stability of the ADP-ribose-arginine 
linkage to hydroxylamine lies between the stability of the 
ADP-ribose-diphthamide bond and the ADP-ribose-cysteine bond 
(76). 
The nonenzymatic product resulting from reaction 
between ADP-ribose and certain acceptor sites are extremely 
stable to hydroxylaminë. The mitochondrial ADP-ribose 
conjugates (73,74) are much more stable towards 3 M 
hydroxylamine than the acid stable adducts formed with 
poly(lysine) and poly(arginine) (12). Picrylsulfonic acid 
decomposes submitochondrial ADP-ribose conjugates, but has 
no effect on poly(lysine) or poly(arginine) (12). Whether 
the hydroxylamine resistant linkages formed in vitro are 
identical to some or all neutral hydroxylamine-resistant 
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mitochondrial ADP-ribose protein conjugates after cell 
fractionation remains to be seen. 
A powerful assay, based on differential chemical 
release, for protein-bound ADP-ribose in cells or tissues 
has recently been introduced by Jacobson et al. (77). This 
method involves the separation of the noncovalently bound 
nucleotides from the covalently bound nucleotides by 
Sephadex 6-25 column. A chemical release of protein-bound 
ADP-ribose is achieved by Incubation at neutral pH in the 
presence or absence of hydroxylamine. The released ADP-
ribose is isolated by affinity chromatography using 
dihydroxyboryl Bio-Rex and reacted with chloroacetaldehyde 
to form highly fluorescent l,N^ -etheno(ADP-ribose). This 
derivative is then quantitated by using strong anion 
exchange HPLC and fluorescence detection. This method is 
very sensitive and does not detect ADP-ribose linkages 
resistant to hydroxylamine cleavage. 
Specificity 
The specificity of these ADP-ribosyltransferases is not 
yet understood. Both prokaryotlc and eukaryotlc mono(ADP-
ribosyl) transferases have been shown to catalyze the ADP-
rlbosylatlon of low-molecular-welght 
17 
Tabla III 
KB valuas for oholara toxln-oatalyiad ADP-ribosylation 
of low-aolaoular-waigtat compound# 
Substrata KM, mK 
Arglnine 75.0 
Agmatlne 35.0 
L-arginine methyl ester 39.0 
Canavanine 
o
 
H
 
p-nltro-benzylamineguanidine 0.8 
Diethylamlne-benzylamlneguanldlne 3.0 
I-guanyltyramine 0.044 
Meta-iodobenzylguanldine 0.0065 
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guanldlne-containing compounds (Table III) (78-81). The Km 
and Vmax values for these compounds have been deterlmlned 
using cholera toxin. The negatively charged group near an 
ADP-ribosylation site seems to decrease the extent of ADP-
ribosylation. Removal of the negatively charged group, as 
in agmatine (see Figure 1 for structures), results in a 
lower Km value (82). Canavanine, which resembles the 
structure of arginine except that it contains an oxygen in 
place of a methylene group, has a much lower Kn (83). Both 
I-guanyltyramine (78) and meta-iodobenzylguanidine (84) have 
a Km value in the micromolar range. Both of these compounds 
are iodinated at the meta position which may increase the 
hydrophobicity. These and other studies suggest that a 
hydrophobic environment around an ADP-ribosylation site 
seems to be an important factor in effective ADP-
ribosylation. 
An ADP-ribosylation factor (ARF), discovered by Kahn 
and Oilman (85), may also contribute to the specificity of 
mono(ADP-ribosyl)ation reactions. ARF, a 21,000 dalton GTP-
binding protein from bovine brain, stimulates cholera toxin-
dependent ADP-ribosylation of the stimulatory regulatory 6-
protein, 6s (86). Two mechanisms have been proposed for the 
activation of ADP-ribosylation by cholera toxin. One is 
19 
+  5 2 -HoN - Ç - C - O f. 
Arglnlne 
+ H 
H3N - Ç- H 
61! 
= NH. 
Agnatine 
+ 99 
H,N - 6 -C -
&2 
2Î2 
gj2 
L"^  
OCH, 
2 
L-Arglnine 
methyl 
ester 
+ 99 
H3M - ç - c - o 
«2 HO CHg- NH- C 
"2 _ ^   ^NH2 
NH + 
C= NH, 
Shj 
Canavanlne I-guanyltyranine 
NH2 
0-' )  ^NH, benzylguanidine 
I 
Meta-iodo-
02N-^ ^^ - CHsN-NH-c/ p-nitro-
 ^  ^ NH2 benzylamine-
guanidine 
+ 
C2HC. %—X .NH2 
N -y CHsN-NH - C Dlethylamine 
CgHg"^  \ T-z/  ^NHg benzylamine-
guanldlne 
Figure 1. structures of the guanidine-eontalning low-
molecular-weight compounds 
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that ARF complexes with 6sa and thereby promotes the ability 
of Gsa to serve as a toxin substrate by increasing the 
availability of the arginine in Gsa that is modified by the 
toxin (87). The second mechanism suggests that ARF 
activation of the toxin is independent of Gsa and results 
from its interaction with the catalytic subunit of the 
toxin. Tsai et al. (88) have shown that, in addition to 
stimulating choleragen-catalyzed ADP-ribosylation of Gsa, 
ARF enhances the auto(ADP-ribosyl)ation of the toxin A-
subunit, the ADP-ribosylation of agmatine, and the 
hydrolysis of NAD+ to ADP-ribose and nicotinamide. Because 
cholera toxin activity is stimulated by an endogenous guanyl 
nucleotide-binding protein and that this protein, ARF, has 
been purified from two different sources, bovine brain (89) 
and rabbit liver (85), it is possible that ARF may be 
involved in regulation of an endogenous ADP-
ribosyltransferase. 
Prokaryotic mono(ADP-ribosyl)transferases are 
extensively studied. The sequence, the secondary structure, 
the target proteins for modification, and the function of 
these bacterial enzymes in eukaryotic systems is known, but 
the specificity requirements for these enzymes are not 
known. All the specificity information to date is known 
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from using the low-molecular-weight guanidine-containing 
compounds. For the eukaryotic mono(ADP-
ribosyl)transferases, everything remains a mystery except 
that they have been detected, in a variety of animal cells 
and some of them have been purified to homogeneity and 
partially characterized. 
ADP-ribosylation reactions have been shown to play some 
role in cellular differentiation (1,33,34). It has been 
shown that NAD+ metabolism is important to the growth of 
mammalian cells in culture (90). Duncan et al. (91) have 
provided some evidence for a link between NAD+ and Ca2+ by 
showing a direct association between the reduction in 
extracellular Ca^ -f and an increase in cellular mono(ADP-
ribose) metabolism in human fibroblasts. Farzaneh et al. 
(1) have shown that a general inhibitor of ADP-ribosylation, 
3-aminobenzamide (3-ABA), reversibly inhibits both fusion of 
myoblasts and the differentiation-specific increase in 
creatine phosphokinase activity. 
3-aminobenzamide is an inhibitor for both poly- and 
mono(ADP-ribosyl)ation reactions (91) and one cannot be 
certain which process(es) are involved. 
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Obj«otlv« 
This dissertation describes the study of (1) the 
relationship between ADP-ribosylation and phosphorylation 
using a model substrate, Leu-Arg-Arg-Ala-Ser-Leu-Gly, which 
is a substrate for both cholera toxin and cAMP-dependent 
protein kinase, (2) the specificity of cholera toxin-
catalyzed ADP-ribosylation reactions using peptides whose 
sequences are derived from the G-proteins, Gsa, Ta, Gia, and 
Goa. Intact proteins Gsa and Ta are substrates for cholera 
toxin. The proteins, Gia and Goa, which possess similar 
sequences near the ADP-ribosylation site in Gsa and Ta are 
not substrates for cholera toxin, and (3) the study of the 
effect of an inhibitor, meta-iodobenzylguanidine (MIBG), for 
arginine-specific mono(ADP-ribosyl)ation reactions in 
primary chick myoblast cultures to obtain some understanding 
of the role of mono(ADP-ribosyl)ation reactions in skeletal 
muscle. In vitro labeling of endogenous proteins in these 
cultures with ^ P^[NAD] is also described. 
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Explanation of Dissartation Format 
This dissertation follows an alternative format in 
which there are three sections after the General 
Introduction. Section I concerns with the relationship 
between ADP-ribosylation and phosphorylation and has been 
published in the Journal q£. Biological Chemistry. Section 
II concerns with the specificity of cholera toxin and 
describes a method for detection of (ADP-ribosyl)arginine 
residues in peptides. Results of section II will be 
submitted to Biochemistry sM Biophysics Research 
Communications. Section III concerns the study of ADP-
ribosylation reactions in cultured myoblasts and will be 
submitted to Experimental Cell Research. Finally, a general 
summary, involving a discussion of further experimentation 
and possible functions of mono(ADP-ribosyl)ation reactions, 
is included. 
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SECTION I. RELATIONSHIP Of PHOSPHORYLATION AND ADP-
RIBOSYLATION USING A SYNTHETIC PEPTIDE AS A 
MODEL SUBSTRATE 
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ABSTRACT 
KemptIde (Leu-Arg-Arg-Ala-Ser-Leu-Gly), is a good 
substrate for cholera toxin in comparison with the -
angiotensin peptides. Because kemptide contains two 
potential ADP-ribosylation sites and, is also a good 
substrate for cAHP-dependent protein kinase, it was possible 
to gain some insight into factors influencing the 
specificity of cholera toxin and to study the relationship 
between phosphorylation and ADP-ribosylation. The ADP-
ribosylated products of kemptide were purified by high-
performance liquid chromatography and characterized by 
peptide sequence analysis, trypsin digestion, and fast-atom 
bombardment mass spectrometry. The major product is 
mono(ADP-ribosyl)ated preferentially on the first arginyl 
residue and some mono(ADP-ribosyl)atlon was observed to 
occur on the second arginine. The minor product is di(ADP-
ribosyl)ated. The Km and Vmax for mono(ADP-ribosyl)ation of 
kemptide are approximately 7.7 ± 2.1 mM and 38.1 ± 5.5 
nmoles min"^  mg~^ , respectively. Phosphorylated seryl 
residue of kemptide almost completely blocks ADP-
ribosylation of the arginyl residues by cholera toxin. 
Mono(ADP-ribosyl)ated kemptide is a poor substrate for the 
cAMP-dependent protein kinase in comparison with kemptide. 
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Dl(ADP-!rlbosyl)ated kenptlde is not phosphorylated at all. 
These results suggest that a mere exposure of an arginyl 
residue in peptides is not a sufficient condition for 
effective ADP-ribosylation and that a relationship exists 
between ADP-ribosylation and phosphorylation. 
27 
INTRODUCTION 
Cholera toxin catalyzes the transfer of the ADP-ribose 
moiety from NAD"*" to a variety of arginine-containing 
proteins and is also known to catalyze the hydrolysis of 
NAD^  to ADP-ribose and nicotinamide (1). Among the most 
widely known proteins ADP-ribosylated by cholera toxin are 
the guanine nucleotide-binding regulatory proteins that 
inhibit the GTPase activity and concomitantly activate 
adenylate cyclase activity (2-4). Cholera toxin also ADP-
ribosylates a variety of low-molecular-weight guanidino-
containing compounds (5-7) and guanylhydrazones (8). Many 
other proteins ADP-ribosylated by cholera toxin have been 
identified (9-13), but there is little knowledge of the 
specificity determinants of cholera toxin. 
ADP-ribosyltransferases are present in many animal 
tissues (14-19), and the presence of enzymes that hydrolyze 
ADP-ribose attached to proteins via arginine linkage has 
been detected (20-22). Recent studies indicate that ADP-
ribosylation may play a vital role in regulation of certain 
metabolic processes. In Rhodospirillum rubrum. a free-
living, purple photosynthetic bacterium, the nitrogenase 
activity is regulated by reversible ADP-ribosylation of a 
specific arginyl residue of dinitrogenase reductase (23,24). 
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Also, several lines of evidence have accumulated that 
suggest a possible regulation of protein phosphorylation by 
ADP-ribosylation. Tanigawa et al. have reported that ADP-
ribosylation of histone (25,26) and phosphorylase kinase 
(27) by hen liver nuclei ADP-ribosyltransferase suppresses 
subsequent phosphorylation by cAMP-dependent protein kinase. 
Our laboratory has reported the presence of an 
endogenous ADP-ribosyltransferase in rabbit skeletal muscle 
(16), and this enzyme has been shown to share many 
properties with cholera toxin (28). Little is known about 
the specificity determinants for these ADP-ribosylating 
enzymes. Kemptide (Leu-Arg-Arg-Ala-Ser-Leu-Gly), an 
excellent substrate for cAMP-dependent protein kinase (29), 
has also been reported to be a good substrate for cholera 
toxin (30). We have found that kemptide is a better 
substrate for cholera toxin than the angiotensin peptides. 
Cholera toxin preferentially catalyzes ADP-ribosylation of 
the first arginyl residue of kemptide and that formation of 
di(ADP-ribosyl)ated kemptide also occurs. Using kemptide as 
a model substrate, we found that ADP-ribosylation suppresses 
phosphorylation by cAMP-dependent protein kinase and that 
phosphorylation almost completely blocks ADP-ribosylation by 
cholera toxin. 
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Protein Sequencer with an on-line Model 12OA 
phenylthiohydantoin amino acid analyzer. A Beckman DU-7 
Spectrophotometer was used for all spectrophotometric 
measurements. 
ADP-ribosylation of peptides An assay mixture 
consisting of 2 mM peptide, 10 mN NAD^ , 20 mM DTT, 50 ng/ml 
cholera toxin *A' subunit, and 100 mM glycine ethyl ester 
buffer (pH 7.6) in a total volume of 25 nl was incubated at 
30°C. Mixture A (consisting of glycine ethyl ester, DTT, 
and cholera toxin) and mixture B (consisting of NAD"*", 
peptide, and HgO) were preincubated at 30°C for 20 min to 
avoid an initial lag in the reaction. The reaction was 
initiated by addition of mixture A to mixture B. Aliquots 
(10 nl) were removed from the assay system at 0 and 30 min 
and added to 10 Ml of 10% TCA to stop the reaction. The 
samples were diluted to 300 jitl, centrifuged, and injected 
into HPLC. The peaks from the chromatogram at 260 nm were 
integrated. 
Purification of ADP-ribosylated products of 
kemptide The reaction system was set up as described 
with 2 mM kemptide in a total volume of 250 nl. After 
incubation for 6-8 hrs at 30°C, the reaction was terminated 
with an equivalent volume of 10% TCA. The contents were 
filtered and injected into HPLC and a larger VYDAC column 
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was used. The chromatography was monitored at 260 nm, and 
the product peaks were collected and lyophilized. The 
lyophilized products were reconstituted with water and were 
again purified by HPLC and lyophilized. The products were 
then reconstituted with water, and the concentrations were 
determined by spectrophotometric measurement of their 
absorbance at 260 nm and by using the extinction 
coefficient for ADP-ribose (15,640 cm'^ ), also 
determined spectrophotometrically. A standard curve for 
mono(ADP-ribosyl)ated kemptide was constructed by using 
HPLC. 
Aoetylation of kemptide Kemptide (0.62 mg) was 
dissolved in 500 nl of saturated solution of sodium acetate 
(pH 8.5) followed by gradual addition of acetic anhydride 
for 1 hr (acetylation was carried out on ice). The 
resulting mixture was stirred for 1 hr. The two products 
formed were purified by reverse-phase HPLC. 
Trypsin digestion The reaction system consisted of 
10 mM CaClg, 100 ng/nl trypsin, 1.84 mM substrate (ADP-
ribosylated products), and 50 mM ammonium bicarbonate (pH 
7.76) in a total volume of 100 nl. After approximately 4 
hrs of incubation at 37°C, the reaction was terminated by 
the addition of 5 ^ 1 of 100% TCA. The contents were 
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filtered and assayed by HPLC, and the chromatograms were 
monitored at 214 and 260 ran. 
Purification of phomphorylmted kernqptide The 
reaction system consisted of 10 mN ATP, 62.5 mM MES (pH 
6.56), 12.5 mN MgCl2, 0.25 mM E6TA, 10 nq/ml of the 
catalytic subunit of cAMP-dependent protein kinase, and 5 mM 
kemptide in a total volume of 500 txl. After approximately 5 
hrs of incubation at 30°C, the reaction was terminated with 
equivalent volume of 10% TCA. The sample was filtered, 
injected into HPLC, and purified by using the larger VYDAC 
column. Subsequent purification steps were identical to 
those for purification of ADP-ribosylated products. The 
concentration of phosphorylated kemptide was determined by 
spectrophotometric measurement of its absorbance at 214 nm 
and by using the extinction coefficient for kemptide (4900 
M"^  cm~^ ). A standard curve for phosphorylated kemptide was 
obtained by using HPLC. 
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RESULTS 
ADP-ribosylatlon of arglnlna-oontaining paptid#* 
The results of Table I show that angiotensin peptides 
and kenptide are substrates for cholera toxin and that not 
all arginyl residues are modified equally. The two 
octapeptides, 3 and 4, essentially differ in the N-terminal 
amino acid, but peptide 4 with an asparaginyl residue seems 
to be a much better substrate than peptide 3 with an 
aspartyl residue. Peptide 2, missing an amino acid at the 
N-terminus, is as good a substrate as peptide 3. Peptide 1, 
an octapeptide with sarcosine (N-methyl glycine) at the N-
terminus, seems to be a better substrate than peptides 2, 3, 
and 4. These preliminary results seem to indicate that a 
hydrophobic amino acid residue near an arginyl residue 
results in increased amount of ADP-ribosylation. Kemptide, 
a heptapeptide containing two arginyl residues, is the best 
substrate for cholera toxin in comparison with the 
angiotensin peptides. ADP-ribosylation of kemptide was 
investigated further because it is a good substrate for 
cholera toxin with two potential sites for ADP-ribosylation, 
and has been shown to be an excellent substrate for 
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TABLE X 
ADP-ribosylatlon of mngiot#mmim peptides 
and kemptlde by cholera toxin 
ADP-ribosylated 
Peptide product 
(1) Sar-Arg-Val-Tyr-Ile-His-Pro-Ala (82%)* 
(2) Arg-Val-Tyr-Ile-His-Pro-Phe (27%) 
(3) Asp-Arg-Val-Tyr-Ile-His-Pro-Phe (25%) 
(4) Asn-Arg-Val-Tyr-Val-His-Pro-Phe (58%) 
(5) Leu-Arg-Arg-Ala-Ser-Leu-Gly (100%) 
*The numbers represent percentage areas obtained by 
integration of the product peak at 260 nm and the 
absorbance at 260 nm is primarily due to ADP-ribose. 
The percentages are computed by making kemptide 100% 
(approximately 1.1 nmoles of mono(ADP-ribosyl)ated 
kemptide was formed). Reaction conditions are given 
in "Materials and Methods." 
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cAMP-dependent protein kinase, making It possible to study 
the relationship between phosphorylation 
and ADP-rlbosylatlon. 
ADP-rlbosylation of kamptid# 
Incubation of kemptlde with NAD'*' and cholera toxin 
resulted In the formation of two products, which were 
separated by reverse-phase HPLC (Figure lA). Both minor 
(peak a) and major (peak b) product peaks absorb at 260 and 
214 nm. Kemptlde absorbs only at 214 nm, and the absorption 
of the products at 260 nm Is most likely due to the ADP-
rlbose moiety. The two product peaks were purified by 
HPLC. 
To characterize the nature of the products, both minor 
and major products and kemptlde were sequenced (Table II). 
The yields of the arglnyl residues and several other 
residues in kemptlde are in the same range. The yields of 
the two arglnyl residues in the major product, in contrast, 
differ by approximately 71%. The lower yield of the first 
arglnyl residue of the major product may suggest that it is 
modified producing mono(ADP-ribosyl)ated kemptlde. In the 
minor product, however, the yields of the two arglnyl 
residues are equally low, possibly suggesting modification 
of both of the arglnyl residues. The elutlon pattern of the 
Figura lA. Cbolara-toxiii oatmlymed ADP-riboaylatloii of 
kaaptlda. The HPLC profile shows the formation 
of two products; a minor (a) and a major (b) 
product. The reaction was incubated for 3-4 
hrs at 30°C. Other conditions are as described 
under "Materials and Methods" 
Figure IB. BPLC analyala of tryptlo digaation producta of 
nono<AOP-riboayl)atad kemptida. The reaction 
system was set up as described under "Materials 
and Methods." The tryptic digests are 
indicated by numbers. The peak eluting at 
approximately 18 min is a contaminant present 
in the reaction mixture and the peak eluting at 
23.5 min is undigested mono(ADP-ribosyl)ated 
kemptide 
Absorbance at 214nm 
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TABLE ZI 
D#t#rmia*tion of th# ##qu#no# 
of ADP-ribo#yl*t#d products 
Amino Acid major product minor product komptid# 
yield (pmol##)* 
Leu 1417 590 1709 
Arg 128 40 136 
Arg 440 39 147 
Ala 1118 406 1235 
Ser 537 186 117 
Leu 554 146 617 
Gly 270 98 170 
A^pproximate yield in picomoles 
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products, the absorption at 260 nm due to the ADP-ribose 
moiety, and peptide sequence analysis suggest that the major 
product may be mono(ADP-ribosyl)ated preferentially at the 
first arginyl residue, and the minor product, di(ADP-
ribosyl)ated. Negative-ion FAB mass spectrometry of the 
major product showed an unprotonated molecular-ion at m/z 
1312, corresponding to the molecular weight of the mono(ADP-
ribosyl)ated kemptide (Mr « 1313). 
The peptides were subjected to trypsin digestion to 
further define the sites of modification. Treatment of the 
minor product with trypsin did not produce any fragments, 
suggesting that both arginyl residues are ADP-ribosylated 
and, as a result, are resistant to cleavage by trypsin. 
Tryptic cleavage of the major product, in contrast, produced 
five peptide fragments (Figure IB). Fragments 2, 4, and 5 
also absorb at 260 nm. Absorbance at 260 nm is due to the 
ADP-ribose moiety of the fragment. Fragment 2 constitutes 
approximately 70% of the total product absorbing at 260 nm, 
and fragments 4 and 5 constitute the remaining 30%. 
Fragments 2, 4, and 5 were purified by reverse-phase HPLC 
and subjected to negative-ion FAB mass spectrometry. Mass 
spectrum of fragment 2 showed an unprotonated molecular-ion 
at m/z 983, corresponding to the molecular weight of the 
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ADP-ribosylated fragment, Leu-Arg(ADP-ribose)-Arg 
(Mr « 984). This fragment can only result from the cleavage 
after the second arginyl residue of the mono(ADP-
ribosyl)ated kemptide, indicating that the first arginyl 
residue of this fragment must be modified and not the second 
because it was shown, using di(ADP-ribosyl)ated kemptide, 
that trypsin will not cleave after an ADP-ribosylated 
arginine. Hence, approximately 70% of the total mono(ADP-
ribosyl)ated product contains the ADP-ribose attached to the 
first arginyl residue. 
Negative-ion FAB mass spectrometry of fragment 5 showed 
an unprotonated molecular-ion at m/z 1042, corresponding to 
the molecular weight of the ADP-ribosylated pentapeptide, 
Arg(ADP-ribose)-Ala-Ser-Leu-Gly (Mr = 1043). A mass 
spectrum of fragment 4 could not be obtained, but it must 
also contain an ADP-ribose moiety because it absorbs at 260 
nm. Both of these fragments were shown to have identical 
sequence, X-Ala-Ser-Leu-Gly, as determined by peptide 
sequencing. The first cycle of Edman degradation did not 
show presence of any amino acid. Because the yield of the 
modified arginyl residues was low for the mono and dl(ADP-
rlbosyl)ated kemptide (Table II), it is highly possible that 
the first residue, X, in the pentapeptide Is ADP-ribosylated 
arginine and, as a result, is not detected. Some breakdown 
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of ADP-ribosyl arginlne may have occurred and is not 
detected because of small quantity of the sample used in the 
analysis. These results indicate that fragments 4 and 5 are 
the same material, Arg(ADP-ribose)-Ala-Ser-Leu-Gly, 
resulting from mono(ADP-ribosyl)ation of the second arginyl 
residue of kemptide. Hence, approximately 30% of the 
mono(ADP-ribosyl)ation may be occurring at the second 
arginyl residue. Fragment 1 was shown to co-elute with the 
dipeptide, Leu-Arg and fragment 3 is likely Ala-Ser-Leu-
Gly, resulting from cleavage after the second arginyl 
residue. Peptide sequence analysis, trypsin digestion, and 
FAB mass spectrometry show that mono(ADP-ribosyl)ation 
occurs preferentially on the first arginyl residue and that 
the minor product is di(ADP-ribosyl)ated. 
Enzymatic and nonensymatio mono(ADP-ribosyl)ation of 
kemptide 
To evaluate the effectiveness of kemptide as a 
substrate for ADP-ribosylation, kinetic studies were 
undertaken, but we were unable to obtain a saturation curve 
for kemptide in presence of 100 mM phosphate buffer (pH 
7.5). The formation of the product was linear with respect 
to substrate concentration. A possible occurrence of a non-
enzymatic mono(ADP-ribosyl)ation of kemptide in the reaction 
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system could explain this phenomenon. Upon incubation of 5 
mM kemptide with 10 mM ADP-ribose, 20 mM DTE, and 100 mM 
phosphate buffer (pH 7.5) at 30°C for 1 hr, HPLC revealed a 
product peak that absorbed at both 214 and 260 nm and co-
eluted with the enzymatic mono(ADP-ribosyl)ated kemptide 
(results not shown). Hence, the linear increase in velocity 
with increasing kemptide concentration may be due to a 
similar type of chemical reaction occurring in the reaction 
system in as much as cholera toxin can catalyze the 
hydrolysis of NAD'*' to ADP-ribose and nicotinamide, providing 
the free ADP-ribose for the chemical reaction. No such 
chemical reaction was observed when kemptide was incubated 
with 10 mM NAD+, 20 mM DTE, and 100 mM phosphate buffer (pH 
7.5). 
To identify the site of chemical modification, kemptide 
was acetylated with acetic anhydride to block the a-amino 
group of kemptide. Incubation of the acetylated kemptide 
products with 10 mM ADP-ribose, 20 mM DTE, and 100 mM 
phosphate buffer (pH 7.6) did not result in the production 
of a chemical product. Enzymatic products were formed when 
the acetylated kemptide was incubated with cholera toxin and 
NAD"*". These results suggest that ADP-ribose reacts with the 
a-amino group of the peptide and does not chemically react 
with the guanidino side-chain group. 
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The nonenzymatic product from the reaction of kemptide 
with ADP-ribose was purified by reverse-phase HPLC. The 
enzymatic and nonenzymatic products were differentiated by 
their sensitivity to 1.0 N hydroxylamine at pH 7.5 at 37°C. 
The enzymatic product was cleaved by hydroxylamine, 
producing free kemptide and a product that co-eluted with 
ADP-ribose. The nonenzymatic mono(ADP-ribosyl)ated 
kemptide, in contrast, was not affected by hydroxylamine 
under the same conditions. 
Because of the nonenzymatic reaction of ADP-ribose with 
the a-amino group of kemptide, high concentrations of 
glycine ethyl ester (100 mM) were included in the reaction 
system to act as a scavanger of any free ADP-ribose 
generated during the reaction. Effectiveness of glycine 
ethyl ester was demonstrated by incubation of kemptide with 
10 mM ADP-ribose, 20 mM DTE, and 100 mM glycine ethyl ester 
(pH 7.6). Reduction in the formation of the nonenzymatic 
product was observed in this system. In the presence of 
glycine ethyl ester, we were able to obtain a saturation 
curve for kemptide (Figure 2). The Km and Vmax values for 
mono(ADP-ribosyl)ation of kemptide are approximately 7.7 ± 
2.1 mM and 38.1 ± 5.5 nmoles min-^  mg"l, respectively. No 
di(ADP-ribosyl)ated kemptide was observed during the 30-min 
incubation time. 
Figura 2. Dmt#rminmtion of Km and Vhmz for kwqptid#. The 
reactions were carried out in glycine ethyl 
ester buffer, pH 7.6, and incubated for 30 min. 
Substrate concentrations were varied from 1.0 mM 
to 11.0 nM. Products were quantified from the 
standard curve. Other conditions are as 
described under "Materials and Methods" 
nmoles of mono(ADP-rîbosyl)afed 
kemptide/ 30 min 
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Effect of ADP-ribo#ylmtiom on phosphorylation 
Mono and di(ADP>ribosyl)ated products of kemptIde were 
used as substrates for cAMP-dependent protein kinase to 
evaluate the effect of ADP-rlbosylatlon on phosphorylation 
(Figure 3). The initial velocity for phosphorylation of 
kemptide is approximately 15-fold greater than the initial 
velocity for phosphorylation of the mono(ADPribosyl)ated 
kemptide. The di(ADP-ribosyl)ated kemptide is not 
phosphorylated at all. These results show that ADP-
ribosylation suppresses phosphorylation. 
Effect of phosphorylation on ADP-rlbosylatlon 
To determine whether phosphorylation of the seryl 
residue of kemptide could affect ADP-ribosylation, kemptide 
was phosphorylated with cAMP-dependent protein kinase, 
purified, and subjected to ADP-ribosylation by cholera toxin 
(Figure 4). Phosphorylated kemptide (Mr = 852) was 
characterized by negative-ion FAB mass spectrometry which 
showed a molecular-ion at m/z 851. Phosphorylated kemptide 
was not ADP-ribosylated during approximately 4 hrs of 
incubation with cholera toxin. With prolonged incubation, 
however, a small amount of phosphorylated kemptide was ADP-
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ribosylated. The phosphate group on the seryl residue 
largely Inhibits ADP-ribosylation of kemptide by cholera 
toxin. 
figure 3. Effect of ADP-riboaylatloii on phosphorylation. 
The assay concentrations are as described under 
"Materials and Methods" with 0.5 mM ATP and 0.25 
mM substrate: kemptide (#), mono(ADP-
ribosyl)ated kemptide (•), and di(ADP-
ribosyl)ated kemptide (A). Aliguots (20/il) were 
removed from the reaction system at various time 
points, and analyzed by HPLC at 214 nm. The 
chrbmatogram was integrated, and the products 
were quantified from the standard curve 
nMOLES of PRODUCT 
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Figur* 4. Effect of Phosphorylation on ADP-ribosylation. 
An assay mixture consisting of 100 sdf glycine 
ethyl ester (pH 7.5), 20 ON DTE, 10 aN NAD'*', 50 
Mg/ml cholera toxin A subunit, and 1.0 mN 
substrate: kemptide (#)and phosphorylated 
kemptide (A) in a total volume of 150 /il was 
incubated at 30°C. Subsequent steps were 
identical to those for determining the effect of 
ADP-ribosylation on phosphorylation 
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DISCUSSION 
The use of a well-defined substrate, Leu-Arg-Arg-Ala-
Ser-Leu-Gly, was important in this study because it allowed 
us to perform preliminary studies on the specificity 
requirements of ADP-ribosylation and to examine the possible 
relationship of ADP-ribosylation and phosphorylation. 
Cholera toxin was used as a model enzyme for guanidine-
specific mono(ADP-ribosyl)transferases because it is well 
defined (31-33) and has similar enzymatic activity to other 
ADP-ribosyltransferases with small-molecular-weight 
guanidino-containing compounds (8,34). This study of 
cholera toxin with peptide substrates shows that mere 
exposure of an arginyl side chain is not a sufficient 
condition for effective ADP-ribosylation. 
Three products, two mono(ADP-ribosyl)ated derivatives 
and a di(ADP-ribosyl)ated peptide, have been identified for 
reaction of cholera toxin with kemptide. Peptide sequence 
analysis, trypsin digestion, and FAB mass spectrometry show 
that approximately 70% of the major mono(ADP-ribosyl)ated 
product is due to a reaction on the first arginyl residue. 
Modification has also been proved to occur on the second 
arginyl residue. The di-product is formed, showing that an 
ADP-ribosyl group on an adjacent arginine residue will not 
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block further reaction. Further information on factors 
influencing ADP-ribosylation was obtained by using a 
phosphorylated peptide. In this case, little ADP-
ribosylation occurred. It is possible, however, that the 
negative charge on the phosphoryl group may weaken the 
interaction between the enzyme and the substrate. The 
negatively charged aspartyl residue of peptide 3 (Table I) 
also seems to reduce ADP-ribosylation. These results show 
that ADP-ribosylation occurs preferentially on the first 
arginyl residue, di(ADP-ribosyl)ation can occur, and that a 
negatively charged group near an arginyl residue blocks ADP-
ribosylation. 
Our studies with kemptide also point out that free ADP-
ribose generated from the hydrolysis of NAD"*" by cholera 
toxin can chemically react with kemptide, producing a 
product that co-elutes with the enzymatic product on HPLC, 
but differs in that it is stable to hydroxylamine. No 
saturation kinetics could be obtained unless glycine ethyl 
ester is used in the reaction mixture. Our results suggest 
that the chemical reaction occurs at the a-amino group of 
the peptide and that the amino group of the buffer, glycine 
ehtyl ester, counteracts this reaction. Hilz et al. have 
demonstrated earlier that free ADP-ribose generated by NAD 
glycohydrolase activity can react nonenzymatically to give a 
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product that is hydroxylamine resistant, but they did not 
identify the acceptor site (35). Hence, further kinetic 
studies should be done under conditions that avoid the 
chemical reaction. ADP-ribosylation of angiotensin peptides 
in glycine ethyl ester buffer (Table I) show that the extent 
of the reaction of these peptides was less in comparison 
with kemptide, further indicating that the environment 
around the reacting arginyl residue influences the 
effectiveness of ADP-ribosylation. Kinetic studies are in 
progress to ascertain more completely the significance of 
these differences. 
The studies of Tanigawa et al. on protein substrates, 
histones (25), and phosphorylase kinase (27) suggest 
strongly that ADP-ribosylation affects protein 
phosphorylation. We found similar results with our model 
peptide substrates, the mono(ADP-ribosyl)ated product being 
phosphorylated more poorly than kemptide and the di(ADP-
ribosyl)ated product not at all. Cyclic AMP-dependent 
protein kinase clearly has a requirement for arginyl 
residues on the amino terminal side of the phosphorylatable 
serine, and ADP-ribosylation could prevent access of the 
modified peptides to the active site region. Tanigawa et 
al. (25) found no effect of phosphorylation on ADP-
ribosylation of histones. This is in contrast to our 
55 
results with a peptide substrate. Because histones contain 
many arginyl residues and, hence, many potential sites for 
ADP-ribosylatlon, the lack of an effect of phosphorylation 
on ADP-ribosylation is not surprising. The study with a 
peptide substrate shows clearly that phosphorylation affects 
ADP-ribosylation in the immediate environment and suggests 
that effects of phosphorylation in proteins might be 
constrained to nearby arginyl residues. Our current work 
and results of Tanigawa et al. suggest a possible 
relationship between phosphorylation and ADP-ribosylation. 
This question is being investigated further in our 
laboratory. 
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SECTION II. SPECIFICITY OF CHOLERA TOXIN-CATALYZED ADP-
RIBOSYLATION USING SYNTHETIC PEPTIDES 
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INTRODUCTION 
Guanine nucleotide-binding regulatory proteins 
(G-proteins) are involved in the transduction of mechanisms 
of a variety of signalling systems. They control an array 
of cellular processes by modulating the concentrations of 
crucial second messengers such as cAMP (1), cGMP (2,3), and 
Ca^ f (4,5,6) within the cell. Members of this family of 
structurally and functionally homologous proteins serve to 
transfer stimulatory or inhibitory signals to intracellular 
targets in response to activation of specific cell-surface 
receptors by light, hormones, neurotransmitters, or other 
chemical signals (7). 
G-proteins are involved in the regulation of retinal 
cyclic GMP-phosphodiesterase (2,3), adenylate cyclase (1), 
phospholipase C and ion channels (8,9). These G-proteins 
are generally found as heterotrimers composed of a, fi, and C 
subunits (3,7). The a subunits, possessing the GTPase 
activity, clearly differ among the members of the family. 
The Ô subunits are highly similar or identical and their 
structures are strongly conserved among different species. 
The C subunits are different among different G-proteins and 
they may be responsible, in concert with the a subunits, for 
the different functions of different G-proteins. The 
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functions of G-proteins are regulated cyclically by 
association of 6TP with the a subunit, hydrolysis of 6TP to 
GDP and phosphate, and dissociation of GDP (3,10,11). 
A remarkable property shared by these guanine 
nucleotide-binding proteins is that they are substrates for 
toxin-catalyzed ADP-ribosylation reactions, where each toxin 
appears to ADP-ribosylate a unique amino acid on its 
specific protein substrate (12). The a-subunit of Go, a 6-
protein which may link the receptors and phospholipase C in 
the phosphoinositide cascade, and the a-subunit of Gi, the 
inhibitory regulatory G-protein, are ADP-ribosylated by 
pertussis toxin (13,14,15). The a-subunit of Gs, the 
stimulatory regulatory G-protein, is ADP-ribosylated by 
cholera toxin (10,16). The a-subunit of transducin. Ta, is 
ADP-ribosylated by both pertussis and cholera toxin (17,18). 
Transducin, a member of the G-protein family, mediates 
visual transduction in the rod and cone cells of vertebrate 
retinas (17). 
Adenylate cyclase is reciprocally controlled by Gs and 
Gi. ADP-ribosylation of Gsa is correlated with decreased 
hormone-stimulated intrinsic GTPase activity and increased 
adenylate cyclase activity. The preferred substrate for 
cholera toxin is the active form of Gsa, GTP-Gsa (19). ADP-
ribosylation of Gsa markedly inhibits its GTPase activity, 
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due to the conformational change, and thus prolongs the 
lifetime of the active species, resulting in activation of 
adenylate cyclase. ADP-ribosylation of Ta by cholera toxin 
also inhibits the intrinsic GTPase activity and results in 
activation of cGMP-phosphodiesterase activity by a similar 
mechanism (19). 
Cholera toxin ADP-ribosylates Arg-174 in Ta (Table I) 
(18). The region surrounding Arg-174 in Ta closely 
resembles the region containing the ADP-ribosylation site, 
Arg-201, in Gsa (20). A similar sequence surrounding the 
amino acid ADP-ribosylated by cholera toxin in Ta and in Ga 
is also found in the G-proteins, the inhibitory regulatory 
subunit, Gia, and Goa. Even though Gia and Goa contain very 
similar sequences to Gsa and Ta, they are not ADP-
ribosylated by cholera toxin (20). 
To study the specificity requirements for cholera 
toxin, four peptides whose sequences are derived from the 6-
proteins. Ta, Gsa, Gia, and Goa, were synthesized, purified, 
and ADP-ribosylated. This is the first study in which the 
peptides containing the sequence surrounding the ADP-
ribosylation site in intact eukaryotic substrates for 
cholera toxin are used in determining the specificity 
requirements for cholera toxin. Only low-molecular-weight 
compounds have been used thus far for cholera toxin and 
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Tabla I 
Homologous *#qu#no## surrounding the ADP-ribosylating site 
in 0-proteins 
169* 174 179 
(1) To : Asp-Val-Leu-Arg-Ser-Arg-Val-Lys-Thr-Thr-Gly 
196 201 206 
(2) Gsa: Asp-Leu-Leu-Arg-Cys-Arg-Val-Leu-Thr-Ser-Gly 
174 179 184 
(3) Gia: Asp-Val-Leu-Arg-Thr-Arg-Val-Lys-Thr-Thr-Gly 
130 135 140 
(4) Goo; Asp-Ile-Leu-Arg-Thr-Arg-Val-Lys-Thr-Thr-Gly 
"Numbers above the amino acids represent the position 
of the amino acids in the sequence of the intact protein. 
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other ADP-ribosyltransferases (21-23). Although Gla and Goa 
contain a region similar to the region containing the ADP-
ribosylation site in Ta and Gsa, these proteins are not 
substrates for cholera toxin in vivo. To see which amino 
acid(s) may be important in determining the specificity, the 
four peptides were ADP-ribosylated by cholera toxin and the 
products were detected by reverse-phase HPLC and 
characterized by trypsin digestion and sequence analysis. 
A method for detection of (ADP-ribosyl)arginine 
residues in peptides was developed using a sequencer and an 
HPLC. A majority of covalently modified amino acid residues 
in proteins are not recognized by amino acid analysis after 
conventional acid hydrolysis because they are acid-labile. 
Edman degradation of proteins and their peptide fragments 
provides an opportunity to identify chemically modified 
amino acid residues, provided that the nature of the 
modification does not interfere with the degradation 
process. 
Edman degradation involves the coupling between 
phenylisothiocyanate (PITC) and the N-terminal amino acid of 
the peptide, cleavage of the PITC-coupled amino acid from 
the amino terminus of the peptide, and detection of 
the phenylthiohydantoin (PTH) derivative of the N-terminal 
amino acid (24). 
66 
Sequenators automate the Edman degradation procedure. 
In the sequencing process, the peptide Is loaded onto a 
preconditioned glass fiber filter paper and the peptide Is 
then coupled to PITC. The PiTC-coupled amino acid is 
cleaved from the rest of the peptide with TFA and the 
derivative, anilinothiazolinone (ATZ), formed is extracted 
from the filter paper by l-chlorobutane and is converted to 
the PTH-amino acid which is then detected on a reverse-phase 
HPLC (25). 
In several instances the PTH-amino acid derivatives of 
modified amino acids are not easily extracted and remain on 
the filter paper. For example, those of oligosaccharide-
linked residues are insoluble in l-chlorobutane (26). The 
32p-labeled 0-phosphoserine derivative fi-eliminates to yield 
poorly extracted Inorganic ^^ P-phosphate (27). 
Wang et al. (28) have developed a procedure for 
determining the location of phosphorylation sites in 
phosphopeptides. The method employs measurement of 32p-
labeled inorganic phosphate release during Edman degradation 
cycles using a gas-phase sequencer. This method is based on 
extracting peptides and inorganic phosphate from portions of 
the sample filter paper at strategic cycles in the sequence 
analysis. 
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Seklne et al. (29) sequenced a peptide which was ADP-
rlbosylated at an asparaglnyl residue and the ADP-rlbosyl 
group was labeled with 32p. They found a low yield for an 
asparaglnyl residue and most of the label was found on the 
filter paper. We also observed low yields for ADP-
rlbosylated arglnyl residues when an ADP-rlbosylated peptide 
was sequenced. As of yet, no procedure has been described 
for determining (ADP-rlbosyl)arglnlne residues In peptides. 
We have developed a procedure by which the derlvatlzed 
ADP(rlbosyl)arglnlne Is extracted from the filter paper 
after sequencing and Is then detected by reverse-phase HPLC. 
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MATERIALS AM) METHODS 
Whatman 6F/C glass nlcroflber filter paper, polybrene, 
TFA, amino acids, their derivatives, and other chemicals 
used in peptide synthesis and peptide cleavage were obtained 
from Applied BioSystems. PTH-arginine was from Sigma. 
Peptide synthesis, amino acid analysis, and peptide 
sequencing were performed by the Protein Facility at Iowa 
State University. Conditions for ADP-ribosylation of 
peptides and trypsin digestion were as described in 
"Materials and Methods" in Section I. A Beckman DU-7 
spectrophotometer was used for all spectrophotometric 
measurements. HPLC conditions were also as described in 
"Materials and Methods" in Section I except buffer B was 
held at 0% for 5 min and then was increased to 30% in 25 min 
and then again to 100% in 10 min. Finally buffer B was 
brought down to 0% in 5 min. 
Circular dichroism spectra were run by Earle Stellwagen 
at the University of Iowa. All CD measurements were made at 
25*C and were scanned from 260 to 200 nm using a time 
constant of 1.0 sec and spectral steps of 0.5 nm. All 
spectra were recorded in quartz cuvettes with 10- or 2- mm 
light path. 
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P#ptid# synthesis peptide sequences (Asp-Ile-Leu-
Arg-Thr-Arg-Val -Lys-Thr-Thr-Gly, Asp-Val -Leu-Arg-Ser-Arg-
Val-Lys-Thr-Thr-Gly, Asp-Val-Leu-Arg-Thr-Arg-Val-Lys-Thr-
Thr-Gly, and Asp-Leu-Leu-Arg-Cys-Arg-Val-Leu-Thr-Ser-Gly) 
from the GTP-binding proteins were synthesized using a 43OA 
Applied BioSystems peptide synthesizer. The synthesized 
peptides were cleaved from the resin using the TFMSA method 
as described in the User Bulletin No. 16 (Applied 
BioSystems, Inc., 1986). The peptides were purified using 
a Beckman 332M HPLC with a VYDAC 218TP C-18 column (10 x 250 
mm) and were characterized by FAB-mass spectrometry. The 
concentrations of the peptides were determined by amino acid 
analysis performed on 420A Applied BioSystems analyzer. 
Peptide sequencing was performed on an Applied Biosystems 
Model 47OA protein sequencer with an on-line Model of 12OA 
phenylthiohydantoin amino acid analyzer. 
AOP-ribosylation of PTH-arginine An assay mixture 
consisting of 5 mM PTH-arginine, 10 mN NAD, 20 mM DTT, 50 
/ig/ml cholera toxin A-subunit, and 100 mM glycine ethyl 
ester (pH 7.5) in a total volume of 250 fil was incubated for 
10 hrs at 30*C. The reaction was terminated with equal 
volume of 10% TCA. The contents were centrifuged and the 
supernatant was injected onto the HPLC. A VYDAC 218-TP 
C-18 reverse-phase column (4.6 x 150 mm) was used for 
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separation and purification of the ADP-ribosylated PTH-
arginine. Elution was accomplished with 5% THF (buffer A) 
and 100% acetonitrile (buffer B) at a flow rate of 0.5 
ml/min. The column was equilibrated in 10% buffer B and 
after 0.4 min, buffer B was increased to 36% in 17.6 min. 
Again, after 10 min, buffer B was increased to 90% in 0.1 
min and after 3.9 min, buffer B was increased to 100%. 
Extraction of PTE-»rginin#(ADP-ribos#) The glass 
fiber filter paper was preconditioned with polybrene as 
described by Touchstone et al. (30). The preconditioned 
filter paper was cut into four pieces and one piece was used 
for each sample. The sample, PTH-arginine(ADP-ribose), was 
spotted onto the preconditioned filter paper and the filter 
paper was allowed to dry. The filter paper containing the 
sample was then immersed into 200 Ml of solvent and was 
vortexed for one minute. The resulting solvent was then 
injected onto the HPLC and the chromatograms were monitored 
and integrated at 260 nm. 
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RESULTS 
ADP-rlbosylation of ayntbatlo p#ptid#m with ##qu#noe# 
derived from the OTP-binding proteins 
The four peptides shown in Table I were ADP-ribosylated 
by cholera toxin. Figure 1 shows the HPLC elution profiles 
at 214 nm of an ADP-ribosylation reaction of the peptides 
with cholera toxin. All four peptides served as substrates 
for cholera toxin. The products are indicated by letters (a 
and b) and the arrow indicates the unreacted peptide. ADP-
ribosylated peptide is more hydrophilic than the peptide due 
to the ADP-ribose moiety, hence, the products (peaks a and 
h) elute before the substrate on the C-18 reverse-phase 
column, since the peptides do not contain any aromatic 
amino acid residues, they do not absorb at 260 nm. The 
products were easily detected since they absorb at 260 nm 
due to the ADP-ribose moiety. The ADP-ribosylated products 
were purified by reverse-phase HPLC and characterized by 
trypsin digestion and sequence analysis. The products (a 
and b) were not well separated for peptides 3 and 4, hence, 
the purified product consisted of both products. A fairly 
good separation was obtained for the products of peptides 1 
and 2 and both products were purified separately. A better 
Figure l. AOP-rlbosylatioa of peptide# in Table I by 
cholera toxin • The HPLC profiles show the 
formation of two products, a and b* The arrow 
indicates the unreacted peptide. The reaction 
was incubated for 12 hrs at 30*C. The reaction 
conditions are as described for ADP-ribosylation 
of kemptide in "Materials and Methods" in 
Section I. The HPLC conditions are as described 
in "Materials and Methods" 
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separation was achieved for the ADP-ribosylated products of 
peptide 1 than as seen in Figure 1 when small amounts were 
injected onto the HPLC. 
To identify the site(s) of ADP-ribosylation, the ADP-
ribosylated products were subject to trypsin digestion. 
Tryptic cleavage of the two separately purified products of 
peptide 1 produced four fragments absorbing at 260 nm 
(Figure 2, products a and h). The major tryptic fragment 
from product a (peak 1) and the major tryptic fragment from 
product b (peak 2) were purified and sequenced (Tables II 
and III, respectively). The sequence of peak 1, from 
product âf was Ser-X-Val-Lys, where X is the ADP-ribosylated 
arginyl residue. These results are consistent with the 
results presented in section I (Table II) in that little or 
no yield was obtained for the ADP-ribosylated arginyl 
residue. Similarly, the sequence for peak 2, from product 
fe, was Asp-Val-Leu-X-Ser-Arg. Again, the yield for the 
amino acid at position X was very low. A small amount of 
arginine was detected (Table III). Peak 1 of tryptic digest 
of product b is the same as peak 1 of tryptic digest of 
product a since they co-eluted. Presence of peak 1 in 
tryptic digest of product b is due to the presence some of 
the product a in product h» 
Figura 2. HPLC anmlymi# of trypsin digestion products. 
The reaction and HPLC conditions are as 
described under "Materials and Methods" in 
Section I. Trypsin digestion of ADP-ribosylated 
(la) product a of peptide 1, (lb) product b of 
peptide 1, (2) product b of peptide 2, (3) 
product (a+b) of peptide 3, and (4) product 
(a+b) of peptide 4. Products a and b are as 
designated in Figure 1. Numbers near each peak 
indicate the tryptic fragments 
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Product a 
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Time.min 
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Table XI 
Sequence determination of the major tryptlc fragment from 
trypsin digestion of ADP-ribosylated product a of peptide 1 
Amino acid . yield (pmoles) 
Ser 
Val 
Lys 
584 
1805 
878 
Table III 
Sequence determination of the major tryptio fragment from 
trypsin digestion of ADP-ribosylated product 6 of peptide l 
Amino acid yield (pmoles) 
Asp 
Val 
Leu 
Arg 
Ser 
Arg 
205 
666 
552 
8 
141 
25 
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Peak 2 (Figure 2, peptide 1) of tryptic digest of 
product a was not characterized but, since it absorbs at 260 
nm, it must have an ADP-ribose moiety attached to one of the 
amino acids. It cannot be a di(ADP-ribosyl)ated product, 
Asp-Val-Leu-Arg (ADP-ribose) -Ser-Arg (ADP-ribose ) -Val-Lys, 
since a di(ADP-ribosyl)ated product would be well separated 
and would elute earlier than the mono(ADP-ribosyl)ated 
product due to its more hydrophilic nature (31). Peak 2 is 
most probably an ADP-ribosylated fragment resulting from a 
nonenzymatic reaction. We have shown in Section I that a 
chemical reaction between ADP-ribose and a peptide can 
occur. The a-NHg group of aspartic acid and the 6-side 
chain of lysine of peptide can chemically react with ADP-
ribose, produced by the glycohydrolase activity of cholera 
toxin. Chemical reactions have been shown to occur with the 
a-NH2 group of certain amino acids and with the side chain 
of lysine (32). 
These results suggest that the second arginyl residue 
in peptide 1 is ADP-ribosylated in the first product, a, and 
the second product, tL. has the ADP-ribose group linked to 
the first arginyl residue. The ratio of the two products, a 
and b, was determined by integration of the product peaks (a 
and h, Figure 1) at 260 nm to be 60/40. These results 
indicate that the second arginyl residue is 
79 
preferentially ADP-ribosylated by cholera toxin. The Kn and 
Vnax for product a of peptide 1 were determined to be 13.1 
mM and 432 nmoles min-^  mg-^ , respectively (Figure 3). The 
Km and Vmax for product h of peptide 1 were 16.5 mM and 244 
min-1 mg-^ , respectively (Figure 3). The preference for 
ADP-ribosylation of the second arginyl residue is reflected 
in the Vmax values. 
For peptide 2, two products were formed (Figure 1). 
Product a was formed only after long incubations (> 6 hrs). 
Due to the presence of small amount of the product, this 
product was not subjected to trypsin digestion. Since 
product a elutes 1 min before the second product and appears 
only after long incubations suggests that it may be di(ADP-
ribosyl)ated. Trypsin digestion of the second peak, b, 
indicated that it is a mixture of two mono(ADP-ribosyl)ated 
products (Figure 2, peptide 2). Elution profile for tryptic 
fragments for ADP-ribosylated peptide 2 is different in 
comparison to other peptides because peptide 2 does not 
contain a lysine residue where trypsin cleavage occurs. 
This results in a larger tryptic fragment having longer 
elution times. The possible 260 nm absorbing tryptic 
fragments produced by trypsin digestion of ADP-ribosylated 
peptide 2 (product fe) are: (1) Asp-Leu-Leu-Arg(ADP-ribose)-
Cys if the first arginyl residue is ADP-
Flgur* 3. Determination of KB and Vmax for peptide 1 (Asp-
Val-Leu-Arg-Ser-Arg-Val-Lya-Thr-Thr-Oly). The 
reaction system consisted of 100 mM sodium 
phosphate buffer (pH 7.5), 10 mM NAD+, 20 mM 
DTT, 50 ng/ml cholera toxin, and various 
concentrations of peptide 1 (3, 5, 7, 10, and 
12 mM). The reaction was incubated for 45 min 
at 30*C, terminated with equal volume of 10% 
TCA, centrifuged, and the supernatant was 
injected onto the HPLC. The product peaks were 
integrated at 260 nm and the nmoles of product 
was computed using a standard curve. A, initial 
velocity of product formation by cholera toxin 
vs. various concentrations of peptide 1, and B, 
double reciprocal plot. The Km and Vmax 
values were 13.1 mM and 432 nanomoles mln-1 
mg-1, respectively, for product a (•) and 16.5 
mM and 244 nanomoles min-^  mg-^ , respectively, 
for product b (•) 
1 /velocity 
"O 
â 
CL 
I it* 
velocity (nmoles/min) 
o o o o o o 
o 
Q. 
CD o 
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ribosylated and (2) Cys-Arg(ADP-rlbose)-Val-Leu-Thr-Thr-Ser-
Gly if the second arginyl residue is ADP^ ribosylated. 
Again, a nonenzynatic reaction is also possible at the a-NH2 
group of aspartic acid. 
The elution times for the tryptic fragments of ADP-
ribosylated peptide 2 (product h) can be predicted on the 
basis of theif hydrophobicity and chain length. Peak 3 
(Figure 2, peptide 2) is likely to be Cys-Arg(ADP-ribose)-
Val-Leu-The-Thr-Ser-Gly since it is the most hydrophobic 
fragment with longest elution time. Similarly, peak 1 is 
likely to be Asp-Leu-Leu-Arg(ADP-ribose)-Cys. The smallest 
peak, 2, is probably a result of a nonenzymatic reaction, 
since the nonenzymatic product was also present in small 
quantity in tryptic digests of peptides 1, 3, and 4. The 
ratio of the two tryptic fragments (peak 1/peak 3), 
determined by integration of the tryptic fragments at 260 
nm, is 54/46. These results suggest that the two arginyl 
residues are almost equally ADP-ribosylated. 
Peptides 3 and 4 were purified and characterized as 
described above for peptide 1. The two ADP-ribosylated 
products formed for these peptides were separated from the 
substrate but could not be separated from each other by 
HPLC. Hence, the purified product consisted of a mixture of 
both products. The tryptic fragments obtained from trypsin 
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digestion of the ADP-ribosylated products of these peptides 
were characterized by comparison of their elution profiles 
to the elution profile of peptide 1 (Figure 2). Because 
peptides 1, 2, and 4 have very similar sequences, the HPLC 
profiles of their tryptic digests were also very similar. 
Table IV summarizes the sequences of the tryptic fragments. 
The elution times vary slightly due to the slight variation 
in the sequences. 
The major tryptic fragment (peak 1) obtained by trypsin 
digestion of an ADP-ribosylated peptide 3 is Thr-
Arg(ADP-ribose}-Val-Lys since this peak co-eluted with the 
tryptic fragment, Ser-Arg(ADP-ribose)-Val-Lys (Table IV and 
Figure 2). Similarly, the major tryptic fragment (peak 1) 
obtained by trypsin digestion of an ADP-ribosylated 
peptide 4 is Thr-Arg(ADP-ribose)-Val-Lys. The ratio of the 
two major tryptic fragments, peak 1/peak 2 (Figure 2), for 
both peptides 3 and 4 is 80/20. These results indicate that 
the second arginyl residue in peptides 3 and 4 is 
preferentially ADP-ribosylated by cholera toxin. 
In the natural protein substrates. Ta and Gsa, only the 
second arginyl residue is ADP-ribosylated. Various 
conditions were used to induce specificity for ADP-
ribosylation of the second arginyl residue in peptide 1 
(Table V). This peptide was selected for this study 
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Table XV 
Amino moid sequenees of th# tryptio fragments 
Peptide Sequenoa Blution 
tima (min) 
(1) Ta 
product A 
peak 1* Ser-Arg(ADP-ribose)-Val-Lys 19.5 
peak 2® (ADP-ribose)Asp-Val-Leu-Arg or 25.0 
Val-Lys(ADP-ribose)-Thr-Thr-Gly 
product b 
peak 1 Ser-Arg(ADP-ribose)-Val-Lys 19.5 
peak 2 Asp-Val-Leu-Arg(ADP-ribose)-Ser-Arg 24.0 
(2) Osa 
peak 1 Asp-Leu-Leu-Arg(ADP-ribose)-Cys 26.5 
peak 2® (ADP-ribose)Asp-Leu-Leu-Arg 28.2 
peak 3 Cys-Arg(ADP-ribose)-Val-Leu-Thr- 29.0 
Thr-Ser-Gly 
(3) Gla 
peak 1 Thr-Arg(ADP-ribose)-Val-Lys 20.5 
peak 2 Asp-Val-Leu-Arg(ADP-ribose)-Thr-Arg 25.0 
peak 3® (ADP-ribose)Asp-Val-Leu-Arg or 26.2 
Val-Lys(ADP-ribose)-Thr-Thr-Gly 
(4) Goa 
peak 1 Thr-Arg(ADP-ribose)-Val-Lys 20.0 
peak 2 Asp-Ile-Leu-Arg(ADP-ribose)-Thr-Arg 26.0 
peak 3® (ADP-ribose)Asp-Ile-Leu-Arg or 27.0 
Val-Lys(ADP-ribose)-Thr-Thr-Gly 
'Peak numbers are as indicated in Figures 2. 
T^hese peaks are probably due to a nonenzymatic 
reaction occurring between free ADP-ribose in the reaction 
system and a free a-NHo group of aspartic acid or the side 
chain of a lysine residue. 
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Tabl# V 
Bffaot of various conditions on th# ADP-ribosylation of 
poptid# 1 by oholorm toxin 
Condition# % product a % product & fold-
#timulation* 
control 62.9 37.1 1.0 
poly-L-Lysine 62.4 37.6 0.5 
(2.5 mg/ml) 
DMPC (1.0 mM) 62.8 37.2 1.1 
control 59.4 41.6 1.0 
ARF (2.4 fM) 61.5 38.5 4.0 
DMPC (3.0 mM) 60.3 39.7 5.5 
ARF + DMPC 62.2 37.2 1.9 
control 61.0 39.0 1.0 
DMSO (10%) 63.0 37.0 1.8 
Sorbitol (1.5 M) 63.0 37.0 2.8 
control 70.0 30.0 1.0 
Propylene 
glycol (10%) 72.0 28.0 2.0 
(15%) 74.0 26.0 2.2 
(20) 75.5 24.5 2.7 
(30) 75.5 24.5 2.4 
control 70.0 30.0 1.0 
ARF + Propylene 
glycol (10%) 73.0 27.0 14.2 
ARF 70.5 29.5 10.3 
Propylene 
glycol (10%) 73.0 27.0 8.6 
*Fold-stimulation is computed by dividing the total 
area of the two products by the total area of the two 
products in the control reaction. The total area was 
obtained by integration of the two product peaks at 260 nm. 
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because the two ADP-ribosylated products could be separated 
on HPLC and the relative amounts of each product could 
easily be quantitated. Organic solvents were included 
because it is known that solvents can induce organized 
structures in peptides (33,34). Most of the organic 
solvents used increased the extent of ADP-ribosylation of 
the peptide, but the preference for ADP-ribosylation of the 
arginyl residues was not affected. A small increase in the 
ratio of product a to product b was observed in the presence 
of 10% DMSO, 1.5 N sorbitol, and 20% propylene glycol (Table 
V). Even ARF, a eukaryotic ADP-ribosylation factor (35) 
increased the extent of ADP-ribosylation but did not affect 
the ratios of the two products. The increase in the extent 
of ADP-ribosylation by the solvents is probably due to the 
stimulation of the catalytic 
A-subunit of cholera toxin. Maximum activation of the 
cholera toxin-catalyzed ADP-ribosylation of peptide 1 
occurred in the presence of both propylene glycol and ARF. 
From these results we speculate that the structure of 
the peptides in solution may be an important factor for 
specificity. The structures of these peptides were 
determined by circular dichroism. The CD spectrum of 
peptide 1 (Figure 4) showed that this peptide exists as a 
random coil in an aqueous solution containing 50 mM sodium 
Figure 4. Circular dichroiam (CD) apectra of peptide 1. 
CD spectra were determined in 50 nM phosphate 
buffer (pH 7.5), in 10% TFE, and in 10% 
propylene glycol (PG) 
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phosphate buffer (pH 7.5). Ten percent propylene glycol, 
which stimulated ADP-ribosylation of peptide 1 by cholera 
toxin, did not induce any structure in the peptide. 
Trifluoroethanol also did not have any effect. Similar CD 
spectra for peptides 2 and 3 in sodium phosphate buffer (pH 
7.5) were also observed (results not shown). A CD spectra 
for peptide 4 was not obtained since it has a sequence very 
similar to peptide 3 and it also must exist as a random 
coil. These results suggest that the specificity that is 
seen in intact protein substrates for cholera toxin is 
probably due to the secondary and/or the tertiary structure 
of the proteins, or interaction of some protein component 
with the substrate. 
Zdentlfioation of (ADP-ribo8yl)arginine in peptides 
A method for identification of (ADP-ribosyl)arginyl 
residues in peptides was developed using HPLC and a 
sequencer. We observed that the yield for the (ADP-
ribosyl)arginyl residues in ADP-ribosylated peptides was 
significantly lower than other amino acid residues in the 
same peptide (see Table II in section I and Tables II and 
III in this section). In Table II (Section I), the yield 
for an unmodified arginyl residue was higher than the 
modified arginyl residue. Why? This phenomenon was 
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observed each time an ADP-ribosylated peptide was sequenced 
(Tables II and III). Sekine et al. (29). also observed 
similar effect when they sequenced a peptide containing an 
ADP-ribosylated asparagine. 
In the sequencing process, the anilinothiazolinone 
(ATZ) derivative formed on the filter paper upon reaction of 
PITC with the N-terminal amino acid is extracted with 
1-chlorobutane. It is possible that the dérivâtized (ADP-
ribose)arginyl residue is not extracted by 1-chlorobutane 
and, as a result, low yield for an ADP-ribosylated arginyl 
residue is observed. The small amount of arginine seen at 
the putative ADP-ribosylated arginine could be due to some 
hydrolysis of the ADP-ribose group during sequencing. 
To develop a procedure by which the derivatized (ADP-
ribosyl)arginine can be extracted and detected by HPLC, PTH-
arginine was ADP-ribosylated by cholera toxin. The ADP-
ribosylated product was purified by reverse-phase HPLC and 
characterized by FAB-mass spectrometry. The purified PTH-
arginine(ADP-ribose) derivative was spotted onto the 
polybrene treated glass fiber filter paper and extracted 
with various solvents (Table VI). Organic solvent, 
1-chlorobutane, normally used as an extractant during 
sequencing did not extract the PTH-arginine(ADP-ribose) 
derivative from the filter paper (Figure 5). Maximum 
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Tabla VI 
Extraction of PTH-argiaina(ADP-ribo«a) darivativa 
Solvant % Raeovary 
l-chlorobutana 0 
2-butanol 0 
50% formic acid 70 
0.5% TFA 26 
25%TPA/0.01% DTT 82 
Pigur# 5. Extraction of PTH-arg(ADP-rlbos«). PTH-arg(ADP-
ribose) was first spotted on the filter paper, 
dried, and was extracted from the glass fiber 
filter paper as described in "Materials and 
Methods." A, arg(ADP-ribose) injected 
as control; B, PTH-arg(ADP-ribose) injected as 
control; C, PTH-arg(ADP-ribose) extracted with 
1-chlorobutane; and D, PTH-arg(ADP-ribose) 
extracted with 25% TFA/0.01% DTT. Peaks of 
interest are indicated by arrows and the peak 
eluting at approximately 5 min is due to TFA 
r 
00 
Absorimce (260 nin) 
«0 
w 
n o 
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recovery was obtained with 25% TFA/0.01% DTT and 70% 
recovery was obtained with 50% formic acid (Table VI). 
These results suggest that the low yields of some arginyl 
residues observed during sequencing may be due to the 
presence of an ADP-ribosylated arginyl residue and the ATZ-
arginine(ADP-ribose) derivative formed on the filter paper 
is not extracted by 1-chlorobutane. 
This method was tested using the ADP-ribosylated 
peptide 1 in Table I. The two major tryptic fragments 
obtained by trypsin digestion of the two products were 
sequenced (Tables II and III). After the final cycle, the 
filter paper was removed from the sequencer and was soaked 
in 200 Ml of 25% TFA/0.01% DTT and vortexed for one minute. 
The supernatant was injected onto the HPLC and a peak which 
co-eluted with the control, PTH-arginine(ADP-ribose), was 
observed (Figure 6). A peak co-eluting with PTH-arg was 
also observed suggesting that some hydrolysis of the PTH-
arg- (ADP-ribose) bond may have occurred after sequencing. 
After sequencing the fragment, Asp-Val-Leu-Arg(ADP-ribose)-
Ser-Arg, the filter paper was left in the sequencer for 
overnight, and hence greater amount of hydrolysis, possibly 
acid hydrolysis due to TFA, of the PTH-arg-(ADP-ribose) bond 
was observed (Figure 6, chromatogram D, peak 2). Twenty-
five percent TFA/0.01% DTT is used during sequencing 
Figure 6. Extraction and detection of PTH-arg(ADP-ribose) 
from the filter paper after sequencing. ADP-
ribosylated peptide 1 was subjected to trypsin 
digestion and the tryptic fragments were 
purified as described in "Materials and Methods" 
in Section I. After sequencing each fragment, 
the filter paper was removed from the sequencer 
and the contents were extracted as described in 
"Materials and Methods." A, PTH-arg as control; 
B, PTH-arg(ADP-ribose) as control; C, extraction 
of PTH-arg(ADP-ribose) from the filter paper 
after sequencing the peptide, Ser-Arg(ADP-
ribose ) -Val-Lys; and D, extraction of PTH-
arg (ADP-ribose) from the filter paper after 
sequencing the peptide, Asp-Val-Leu-Arg(ADP-
ribose) -Ser-Arg. All extractions were done with 
25% TFA/0.01% DTT. Peak 1 in chromatograms C 
and D is PTH-arg(ADP-ribose). The peak 2, 
indicated by the arrows in chromatograms C and 
D, is the product, PTH-arg, resulting from 
breakdown of PTH-arg(ADP-ribose) after 
sequencing. Peak 3 is unknown. The peak 
eluting at approximately 5 min is due to TFA 
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to convert the unstable ATZ-aulno acid to the stable 
derivative, PTH-amino acid (25). Hence, during extraction 
with 25% TFA/0.01% DTT, the ATZ-arginine(ADP-ribose) 
derivative will be most likely converted to the PTH-
arginine(ADP-ribose) derivative. Although some breakdown of 
the arginine-(ADP-ribose) linkage was observed, the (ADP-
ribose)-arginine linkage seems to be quite stable to the 
repetitive harsh conditions used during sequencing. 
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DZ8CU88Z0V 
We have used peptide substrates with the sequences 
derived from the GTP-binding proteins. Ta, Gsa, Gia, and 
Goa, to study the specificity requirements for cholera 
toxin. Two of these proteins, Gsa and Ta, are natural 
substrates for cholera toxin. The other two, Gia and Goa, 
possess a region similar to the region containing the ADP-
ribosylation site in Gsa and Ta, but are not ADP-ribosylated 
by cholera toxin. 
The major difference in the peptides is the amino acid 
between the two arginyl residues. The peptides with 
sequences from the proteins, Gsa and Ta, ADP-ribosylàted by 
cholera toxin contain a cysteinyl and a seryl residue, 
respectively, between the two arginyl residues. Peptides 
with sequences from Gia and Goa, which are not ADP-
ribosylated by cholera toxin, contain threonyl residues. We 
speculated that this amino acid between the two arginyl 
residues may make some contribution to the specificity 
observed in ADP-ribosylation of the native G-proteins by 
cholera toxin. 
The results show that all four peptides served as equal 
substrates for cholera toxin and that the second arginyl 
residue in peptides 1, 3, and 4 was preferentially ADP-
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ribosylated. The two arginyl residues in peptide 2 (Gsa 
peptide) were almost equally ADP-ribosylated. 
Interestingly, the arginine that is preferentially ADP-
ribosylated is also the site of modification in intact 
proteins, Gsa and Ta. This preference was greater for the 
peptides of Gia and Goa. We expected to see preference for 
the second arginyl residue to be greater in peptides Gsa and 
Ta. These results suggest that the structure of the region 
surrounding the ADP-ribosylation site or even the structure 
of the entire protein may be very important in determining 
the specificity observed in ADP-ribosylation of these 6-
proteins. 
The peptides had no structure in aqueous solution. The 
CD spectrum showed that they existed as random coils. 
Propylene glycol and TFE did not induce any structure in the 
transducin peptide (peptide 1). The ADP-ribosylation 
reaction of peptide 1 (Table I) with cholera toxin was 
stimulated by propylene glycol, DMSO, and sorbitol but the 
specificity for the arginyl residues was not affected. The 
stimulation of the ADP-ribosylation must be due to the 
interaction of the solvents with cholera toxin. Even ARF 
did not induce specificity. 
The results suggest that the specificity determinants 
other than the primary sequence are involved. The secondary 
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and tertiary structures may be very important factors in 
determining the specificity. Cholera toxin seems to ADP-
ribosylate a number of proteins in vitro (36,37). The 
preferred substrate for cholera toxin is the active form of 
Gsa and Ta, Gsa-GTP and Ta-GTP, respectively (19). It is 
highly possible that GTP may induce some conformational 
change in Gsa which makes it the preferred substrate for 
cholera toxin. GaBC is not a substrate for cholera toxin 
possibly due to the blockage of the region containing the 
ADP-ribosylation site by the B and C subunits. A negative 
environment near the ADP-ribosylating site may also be an 
important factor. In our earlier studies with peptide 
substrates, we showed that a negative group around the ADP-
ribosylation site results in decreased amount of ADP-
ribosylation by cholera toxin (31). Other studies with low-
molecular-weight compounds also suggest that negatively 
charged groups around the ADP-ribosylation site suppress 
ADP-ribosylation by cholera toxin (21-23). Using longer 
peptides, 20 or more amino acids, may provide some clues as 
to the importance of structural properties of proteins in 
determining specificity. These longer peptides will have 
more variations in the sequences from one G-protein to 
another and, hence, each peptide will assume a different 
structure. 
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We have shown that the derivatized (ADP-ribose)arglnyl 
residue Is fairly stable to Edman degradation chemistry and 
Is not extracted with 1-chlorobutane. The ATZ-arglnlne(ADP-
rlbose) derivative can be extracted and converted to PTH-
arginlne(ADP-rlbose) with 25% TFA/0.01% DTT and detected by 
reverse-phase HPLC. The procedure developed Is effective In 
detecting ADP-rlbosylated arglnyl residues In peptides. 
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SECTION III. EFFECT OF AN AROININE-SPECIFIC MONO(ADP-
RIBOSYL)TRANSFERASE INHIBITOR ON PRIMARY 
CHICK SKEZIETAL MYOBLAST CELL CULTURES 
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ABSTRACT 
Arglnine-speclflc mono(ADP-ribosyl)transferase activity 
was detected in primary chick myoblasts. An arginine-
specific ADP-ribosylhydrolase activity was also detected in 
these myoblasts (Kim, E-S.; Graves, D. J. (1990) Anal. 
Biootaem. 187, 252-257). The effect of a novel inhibitor of 
cellular arginine-specific mono(ADP-ribosyl)transferases, 
meta-iodobenzylguanidine (MIB6), on differentiation of 
cultured myoblasts was examined. NIB6 reversibly inhibited 
both proliferation and differentiation of embryonic chick 
myoblasts grown in culture. Micromolar (30 pM) 
concentrations of MIB6 blocked fusion, differentiation-
specific increase in phosphocreatine kinase activity, both 
DNA and protein accumulation, expression of a muscle-
specific protein, titin, and also decreased the total NAD 
levels. Meta-iodobenzylamine, an analog of MIB6 missing the 
guanidine group, had no effect. Low concentrations of 
methylglyoxal bis-guanylhydrazone (M6B6), a substrate for 
cholera toxin with a higher Km, also had no effect, but 
higher concentrations of M6B6 reversibly inhibited fusion. 
These findings suggest a possible role for mono(ADP-
ribosyl) at ion reactions in myogenesis. 
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In vitro labeling of cultured myoblast proteins with 
^^ P[NAD] was also examined. A 32,000 dalton protein band 
was predominantly labeled and the labeling of a 42,000 
dalton protein band was inhibited by the presence of DTT. 
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INTRODUCTION 
ADP-rlbosyltransferases catalyze the transfer of the 
ADP-ribose moiety from NAD+ to proteins (1,2). Mono(ADP-
ribosyl)ation reactions are catalyzed by both prokaryotic 
and eukaryotic enzyme systems. Bacterial ADP-
ribosyltransferases are well studied and the target proteins 
have been identified and characterized (3). They regulate a 
variety of cytoplasmic functions such as protein translation 
(diphtheria toxin) (4) and signal transduction at the plasma 
membrane (cholera and pertussis toxin) (5,6). Poly(ADP-
ribosyl)ation has been shown to be involved in regulation of 
DNA repair, cell differentiation, and in malignant 
transformation (7,8,9). Little is known about eukaryotic 
mono(ADP-ribosyl)transferases. They are present in many 
animal tissues (10-16) and eukaryotic enzymes capable of 
removing ADP-ribose from acceptor proteins have also been 
described (17-19). Arginine-, diphthamide- and cysteine-
specific ADP-ribosyltransferases have been detected in 
animal systems (16,20,21) in various cell compartments. 
Nuclear, cytosolic, and membrane mono(ADP-
ribosyl) transferases have been reported (22) . Mono(ADP-
ribosyl) ation predominates by far over 
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poly(ADP-ribosyl)atlon in mammalian cells, particularly in 
the extranuclear compartments. 
Involvement of ADP-ribosylation reactions in 
differentiation of myoblasts has been reported. Shall and 
his associates (7) have shown that addition of a specific 
inhibitor of ADP-ribosylation, 3-aminobenzamide (3-ABA), to 
primary chick myoblast cell cultures reversibly inhibited 
both the fusion of myoblasts and the differentiation-
specific increase in phosphocreatine kinase activity. These 
results provide evidence for a function of ADP-ribosylation 
in regulating myoblast differentiation. The concentration 
of the inhibitor used in this study can block both poly- and 
mono(ADP-ribosyl)ation, and, thus, one cannot ascertain 
which process was involved (23). Shall and coworkers 
suggested that the effect of 3-ABA was due to an effect on 
poly(ADP-ribosyl)ation. However, the possibility that 
inhibition of mono(ADP-ribosyl)ation might also have been 
involved in the observed response cannot be ignored. 
We have used a specific inhibitor, meta-iodo-
benzylguanidine (MIBG), of arginine-specific cellular ADP-
ribosyltransferases in primary chick myoblast cultures to 
gain some understanding of the physiological role of 
mono(ADP-ribosyl)ation reactions. It has been shown that 
MIBG does not interfere with the poly(ADP-ribose) polymerase 
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activity of S49 cells, but it is a very effective inhibitor 
of arginine-specific mono(ADP-ribosyl)ation (24). MIBG has 
gained considerable interest as a tumor-seeking 
radiopharmaceutical for diagnosis and treatment of neuro­
endocrine tumors (25). Moreover, both MIBG and an ADP-
ribosylation inhibitor, nicotinamide, have been shown to 
potentiate the leukemolytic action of glucocorticoid 
hormones (26). 
We have found an arginine-specific ADP-
ribosyltransferase activity in nuclear, cytosolic, and 
membrane fractions of primary chick myoblasts. An arginine-
specific ADP-ribosylhydrolase activity was also found in 
these myoblasts previously in our laboratory (27). The 
effect of MIBG on differentiation of cultured myoblasts was 
examined. The results suggest a possible role of arginine-
specific mono(ADP-ribosyl)ation reactions in myogenesis. 
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MATERIALS AMD METHODS 
All reagents were of analytical grade. ^^ P[NAD] was 
from ICN Radiochemicals, DTT and BCA protein assay reagent 
were from Pierce, Salmon sperm DMA was from Calbiochem 
Corp., 3,5-diaminobenzoic acid dihydrochloride (DABA) and 
meta-iodo-benzylamine were from Aldrich Chemical Co., Kodak 
X-OMAT-AR film was from Eastman Kodak Company, and CK-10 
single reagent system for creatine kinase assay, N6BG, and 
NAD were obtained from Sigma. Culture media and horse serum 
were from 6IBC0. The anti-titin antibody was made by Dr. 
Huiatt's laboratory at Iowa State University and the 
rhodamine labeled goat anti-mouse antibody was from 
Cappelle. MIBG, synthesized from meta-iodobenzylamine 
according to Wieland et al. (25), was provided by Jon 
Peterson. 
High-performance liquid chromatography was performed on 
a Beckman 332M liquid chromatograph with a Beckman 165 
Variable Detector interfaced with a Nelson Analytical 3600 
Data System. A reversed phase ZORBAX-ODS (21.2 mm x 25 cm) 
column with a flow rate of 1.0 ml/min was used for detecting 
ADP-ribosyltransferase activity. Elution was accomplished 
with .0435 M.sodium acetate, pH 4.0, (buffer A) and 
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açetonitrlle (buffer B). A linear gradient from 0 to 61 % 
buffer B in 35 min and then to 100% buffer B in 5 min was 
used. 
Cell cultures Twelve day incubated chick embryos 
were purchased from Hy-Vac Laboratory Eggs. Skeletal muscle 
cells were isolated from mixed leg and thigh muscles of 12-
day chick embryos by mechanical dissociation according to 
Ridpath et al. (28). After filtration, the single cell 
suspension was preplated at 37*C for 40 min to 
differentially remove fibroblasts. Cultures were plated in 
collagen coated Falcon tissue culture dish. Cells were 
maintained by daily feeding in Dulbecco's MEM, 10% horse 
serum, 1% antibiotics, and 2.5% chick embryo extract. 
Cultures were incubated at 37*C in an atmosphere of 5% COg 
and 95% air. 
Measurement of cell fusion Plates were rinsed three 
times with phosphate buffered saline (PBS, pH 7.5), fixed 
for 5 minutes in methanol, stained with Geisma stain, and 
were rinsed and stored in water until counted. Cell fusion 
was determined by direct microscopic examination at a total 
magnification of 400X. 
Detection of titin The cells were fixed with 
methanol, stained with anti-titin monoclonal antibody with 
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rhodamlne labeled goat anti-mouse, and the cells were 
examined under fluorescence microscope. 
Preparation of cell extracts Cells were washed 
three times with PBS (pH 7.5) and were harvested in PBS 
using a rubber policeman. The cells were collected by 
centrifugation (800xg, 5 min) and were swelled and 
homogenized in pH 7.5 buffer (50 mM Tris-HCl, 1.0 mN 
Benzamidine, 1.0 mM EDTA, 1.0 mM lodoacetamide, 0.23 mM 
PMSF, and 0.03% Nonidet P-40). To obtain various fractions, 
the homogenate was centrifuged (800xg, 5 min) to obtain the 
nuclear pellet, and the resulting supernatant was again 
centrifuged (100,000xg, 90 min) to obtain high speed 
supernatant and a pellet. Protein was determined using the 
BCA (Bicinchoninic Acid) protein assay reagent. The whole 
cell homogenate, nuclear pellet, 100,000xg supernatant, and 
100,000xg pellet were assayed for ADP-ribosyltransferase 
activity. 
ADP-ribosyltransferase activity assay The reactions 
were performed in a final volume of 100 (il containing 100 mM 
sodium phosphate (pH 7.5), 10 mM NADf, 2 mM MIB6 and various 
concentrations of myoblast protein. After 3 hrs and 20 min 
of incubation at 30'C, equal volume of 10% TCA was added to 
terminate the reaction. The samples were diluted to 220 fil, 
115 
centrifugea, and injected onto HPLC. The product peaks at 
260 nm were integrated. The (ADP-ribose)MIBG was 
quantitated using a standard curve for mono(ADP-ribosyl)ated 
MIBG which was constructed using an HPI£. 
Phomphooremtim# kiams# (PCX) motivity, DMA and protein 
determination The cells were washed three times with 
PBS, pH 7.5. The cell surfaces were covered by the addition 
of 0.25 ml of 0.05 M glycylglycine buffer, pH 6.75, and were 
frozen at -70"C (28). To determine the PCK activity, the 
total DNA content, and the total protein content, the cells 
were thawed on ice and harvested with a rubber policeman. 
The cell suspension was then sonicated for 15 sec and 
vortexed. 
Sigma diagnostic kit and the accompanying procedure was 
used for determination of PCK activity. Briefly, the CK 
reagent was reconstituted with deionized water and 1.0 ml of 
CK reagent was added to a cuvet. An aliquot of the 
sonicated cell homogenate was added and the contents were 
mixed. After 3 min, absorbance at 340 nm was recorded at 
30-sec intervals for a period of 120 sec. The PCK activity 
was calculated by using the millimolar absorptivity of NADH 
(6.22 at 340 nm). 
The DNA content was measured by the fluorometric assay 
of Erwin et al. (30), using a salmon sperm DNA as a 
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Standard. A standard curve was established for each 
experiment. The fluorescence of the product was determined 
with a SPEX DATAMATE fluorometer with a fixed excitation 
wavelength at 400 nm and a fixed emission wavelength of 
520 nm. The protein content was measured using the BCA 
protein assay reagent. 
NAD+ determination Levels of NAD+ in primary 
myoblast cultures were determined using the procedure 
described by Jacobson and Jacobson (31). 
Endogenous AOP-ribosylation Endogenous ADP-
ribosylation was measured in crude myoblast preparations. 
The reaction system consisted of 50 mM Tris-HCl (pH 7.5), 
1.0 mg/ml cell homogenate in a total volume of 200 /il. The 
reaction was initiated by addition of ^ P^[NAD] (0.77 mM, 200 
cpm/pmol), incubated at 30"C, and was terminated by addition 
of equal volume of cold 10% TCA. The protein was allowed to 
precipitate at 4*C for 2 hrs and the precipitate was 
collected by centrifugation. The pellet was washed three 
times with diethyl ether. The pellet was dissolved in 40 jul 
of 2X treatment buffer (0.125 M Tris-HCl, pH 6.8, 4% SDS, 
20% glycerol, 10% 2-mercaptoethanol), boiled for 5 min, and 
15 nl of the sample were subjected to SDS-PA6E in 10% linear 
polyacrylamide gel. The gel was stained with coomassie 
blue, destained in 5% methanol and 7% acetic acid, dried. 
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and was exposed to Kodak X-OMAT-AR film. Total labeling of 
proteins by at various times was determined by using the 
filter paper assay as described by Relmann et al. (32). 
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RESULTS 
AxglniBtt-spaolflo ADP-ribo#yltrmn#ferm## activity in primary 
ohiok ayoblaats 
Meta-iodobenzylguanidine was used as a substrate to 
detect the ADP-ribosyltransferase activity present in 
primary chick myoblasts. An HPLC assay using a reversed-
phase C-18 column was used to detect the product, (ADP-
ribose)MIB6. Incubation of MIB6 with NAD and the cell 
homogenate resulted in the formation of two products, <%- and 
fi-anomers of (ADP-ribose)MIBG (peaks a and b) as shown in 
Figure 1. These two products were also produced when MIB6 
was incubated with NAD+ and cholera toxin. 
To localize the enzyme, cells from 72 hr cultures were 
homogenized and fractionated as indicated in "Materials and 
Methods." As shown in Table I, all three fractions, the 
nuclear pellet, the 100,000xg supernatant, and the 100,000xg 
pellet, contained arginine-specific mono(ADP-
ribosyl)transferase activity. Highest specific activity was 
found in the 100,000xg pellet. Since fibroblasts are 
present in the primary myoblast cultures, they were also 
assayed for ADP-ribosyltransferase activity. No arginine-
specific mono(ADP-ribosyl)transferase activity was detected 
in fibroblast cultures. 
Figure 1. ADP-rlbosyltransferase activity in primary ohiek 
myoblasts. The cells were washed three times 
with PBS, pH 7.5, harvested, and sonicated for 
1.0 min as described in "Materials and Methods." 
ADP-ribosyltransferase activity in the whole 
cell homcgenate was assayed using MIBG as a 
substrate. HPLC and reaction conditions are as 
described in "Materials and Methods." A, cholera 
toxin + NAD + MIBG; B, whole cell 
homogenate + MIBG; C, whole cell 
homogenate + NAD; and D, whole cell 
homogenate + NAD + MIBG. The two products are 
indicated by letters a and b 
Absorbance (260 nm) 
w O 
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Table I 
AOP-rlboayltranafaraaa motivity in yarioua frmotiona* 
Fraotiona Spaoifio Activity 
(omolaa/mg protain) 
7Ï) whole cell homogenate 0.55 
(2) homogenate without nuclear pellet 2.23 
(3) nuclear pellet 1.47 
(4) lOOfOOOxg supernatant 1.36 
(5) lOOfOOOxg pellet 4.21 
*Seventy-two hour chick myoblast cultures were used. 
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Effect of MIBO OB fusion of primary ohiok myoblast# 
To Investigate the effect of MIB6, an inhibitor of 
cellular arginine-speciflc (ADP-ribosyl)transferases, on the 
fusion and differention of muscle cells, primary chick 
myoblast cell cultures were fed with media containing MIB6 
concentrations of 15, 30, and 60 fM (Figure 2). Control 
cultures demonstrated a nearly linear increase in cell 
fusion from 24-72 hrs in culture. The small decrease 
observed from 72-96 hrs was due to continued proliferation 
of nonfusing cells, presumably fibroblasts present in the 
primary cultures. Little increase in % fusion was observed 
in MIBG treated cultures. Inhibition of myoblast fusion by 
MIB6 was observed in cultures as early as 48 hrs and most of 
the fusion was blocked at a very low concentration of MIBG 
(15 fM), The control cell cultures contained a network of 
growing multinucleated fibers of different sizes (Figure 
3A). In contrast, cultures containing MIBG consisted of 
mononucleated cells and there was abundance of the spindle-
shaped myoblasts (Figure 3B). 
The inhibition of fusion was reversible (Figure 2). 
Replacement of MIBG-containing medium with normal medium at 
72 hrs reversed the inhibition and resulted in the rapid 
initiation of cell fusion. Formation of multinucleated 
fibers was observed in cultures where the MIBG-containing 
Figura 2. Effect of MIBG on fusion of primary chick 
myoblasts, cell cultures were grown as 
described in "Materials and Methods" and were 
treated with various concentrations of MIBG. 
Cell fusion was measured as described in 
"Materials and Methods" in cultures treated with 
normal medium (•), in cultures treated with a 
medium containing 15 /xM MIBG (+), 30 /iM MIBG 
W, and 60 fM MIBG (A). Dotted lines indicate 
the reversal of the MIBG effect upon replacement 
of the MIBG-containing medium with a normal 
medium at 72 hrs 
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Figura 3. Bffaot of MIBG on muaol# call fusion. (A) 
control cultures at 48 hrs; (B) cultures treated 
with a medium containing 30 pM MIBG for 24 hrs 
(C) reversal of inhibition of fusion by 
replacement of MIBG-containing medium with 
normal medium after 24 hrs of treatment with 30 
/xM MIBG. All cells were grown, fixed, and 
stained as described in "Materials and Methods" 
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medium was replaced with normal medium (Figure 3C). Forty-
eight hours after the reversal of MIB6 treated cells, 40% of 
the cells were fused. In the control samples, maximum of 
55% fusion was obtained. The reversibility of fusion 
suggests that MIB6 did not cause cell death and hence, did 
not impair the cells capacity to fuse. 
Since MIB6 is structurally related to norepinephrine 
(25), it was investigated if MIB6 acted as a false hormone. 
We found that norepinephrine had no effect on primary chick 
myoblasts. To see if the effect was due to the starting 
material, meta-iodobenzylamine (MIBA), or to the guanidino 
group of MIB6, MIBA (60/xM) was also tested in chick 
myoblasts as well. MIBA had no effect on cell fusion. 
Methylglyoxal bis-guanylhydrazone (M6B6), a known 
substrate for cholera toxin containing two guanidino groups 
with a Km of 2 mM (33), was also used in myoblast cultures 
to obtain further evidence as to the importance of the 
guanidine group in the effects elicited by HIB6. Low 
concentration of M6B6 (60 fM) had no effect on myoblast 
cultures while higher concentration of M6B6 (1.0 mM) 
produced similar effects as MIBG and this effect was also 
reversible. This result is consistent with the fact that 
the Km for M6BG is in the millimolar range, hence, higher 
concentration of MGBG is probably required to interfere with 
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an arginine-speclfic mono(ADP-rlbosyl)transferase present in 
myoblast cultures. These results suggest that the 
guanidino-group seems to be essential in eliciting the 
effects observed with MIB6 and N6BG, and that they might be 
exerting these effects by interfering with an arginine-
specific mono(ADP-ribosyl)transferase. 
Effect of NZBO on PCX activity 
Morphological differentiation of muscle cells in 
culture is correlated with changes in the activity of 
several enzymes involved in the provision of energy for 
muscle contraction (34). Therefore, the effect of MIB6 on 
PCK activity was examined. Primary chick myoblasts were 
treated with 30 fM MIBG. At 24, 48, and 72 hrs, the cells 
were harvested, sonicated, and assayed for PCK activity 
(Figure 4). The PCK activity decreased significantly in the 
presence of MIBG in cell cultures. This process was 
reversible. Twenty-four hours after the reversal, only a 
slight increase in PCK activity was observed. A large 
increase in activity was observed after 48 hrs of reversal. 
/ 
Effect of MIBG on arginine-specific mono(ADP-ribosyl)-. 
transferase activity ADP-ribosyltransferase activity was 
detected in 24, 48, 72, and in 96 hr cell cultures as 
Figure 4. Effect of MIBQ on VCK activity. The cell 
extracts were prepared as described in 
"Materials and Methods." PCK activity was 
determined in cell cultures treated with normal 
medium (•), in cultures treated with a medium 
containing 30 /xM MIBG (+), and in cultures 
reversed at 48 hrs (a), and at 72 hrs (O)• 
Cultures were reversed by replacing the MIBG-
containing medium with a normal medium 
PCK Activity (mUllunlto/mg pretoln) 
CnieuMnda) 
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shown in Figure 5. Low levels of ADP-ribosyltransferase 
activity were found during the first 2-days of growth in 
culture (at 24 and 48 hrs). On the third day (72 hr 
culture), a prompt increase in the level of ADP-
ribosyltransferase activity was observed. In cultures fed 
with HIB6 containing media, the activity declined after 24 
hrs of treatment (24-48 hrs in culture) and remained at low 
levels. Replacement of MIBG-containing medium with normal 
medium at 48 hrs reversed the inhibition and an increase in 
the ADP-ribosyltransferase activity was observed. 
Effect of MIBO on DNA and protein content 
Neta-iodobenzylguanidine (30 (M) caused a decrease in 
both the total DNA (Figure 6) and total protein (Figure 7) 
content and this inhibition was also reversible. Within 
24 hrs following the reversal, the DNA content increased in 
parallel with the protein content. This may indicate that 
the effect on DNA synthesis could possibly be related to the 
inhibition of protein synthesis. A requirement for protein 
synthesis prior to and during DNA synthesis in mammalian 
cells has been reported (35). 
Figure 5. Effect of MIBO on arginine-speoifie mono(aDP-
ribosyl)transferase activity. The cells were 
washed three times with PBS, pH 7.5, harvested, 
and sonicated for 1.0 min as described in 
"Materials and Methods." ADP-ribosyltransferase 
activity was assayed in the whole cell 
homogenates of myoblast cultures treated with 
normal medium (•), in cultures treated with a 
medium containing 30 fiM MIBG (+), and in 
cultures reversed at 48 hrs (O)• Cultures were 
reversed by replacing the MIBG-containing medium 
with a mormal medium. HPLC and reaction 
conditions are as described in "Materials and 
Methods" 
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Figure 6. Effect of MIBQ on the total DlOk content. The 
cell extracts were prepared and the DNA content 
was measured as described in "Materials and 
Methods." Total DNA content was measured in 
myoblast cultures treated with normal medium 
( • ), in cultures treated with a medium 
containing of 30 nK MIBG (+), and in cultures 
reversed at 48 hrs (A), and at 72 hrs (o) • 
Reversal was done as described in Figure 5 
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Figure 7. Effect of MZB6 on th# total protein content. 
The cell extracts were prepared and the protein 
content was determined as described in 
"Materials and Methods." Total protein content 
was determined in myoblast cultures treated with 
normal medium (a), in cultures treated with a 
medium containing 30 /iM MIBG (+), in cultures 
reversed at 48 hrs (A), and at 72 hrs (O)• 
Again, reversal was done as described in 
Figure 5 
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Effect of NZBG on MAD levels 
The pyridine nucleotides play key roles in cellular 
metabolism. NAD is also a substrate for ADP-
ribosyltransferases. Therefore, the effect of MIB6 on NAD 
levels in primary myoblast cultures was determined (Figure 
8). Low levels of NAD were observed in the control cells at 
24 hrs and the levels of NAD increased until 48 hrs. From 
48 to 72 hrs, no change in NAD levels was seen. In cultures 
treated with MIB6, a decrease in the total NAD levels was 
observed. MIBA (60 fiM) and M6BG (60 /xN) had no effect on 
the NAD levels (results not shown). The mechanisms that 
regulate the levels of NAD within the cells are not well 
understood, but it has been shown that the levels appear to 
be significantly lower in dividing cells than in non-
dividing cells (31). 
Endogenous ADP-ribosylation 
SDS-PAGE analysis of the ADP-ribosylation reaction.of 
cell homogenate of primary chick myoblasts in the presence 
of.^ P^[NAD] demonstrated the incorporation of ^ P^ in several 
bands (Figure 9). Since MIB6 had various effects on 
myoblasts in culture, we studied its effect on endogenous 
labeling of proteins in vitro. A slight of amount of 
Figura 8. Effect of NIBO on MAD levels. The cell extracts 
were prepared and the NAD levels were determined 
as described in "Materials and Methods." NAD 
levels were determined in myoblast cultures 
treated with normal medium (u), and in cultures 
treated with a medium containing 60 nVL MIB6 (+) 
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Figure 9. An mutormdiogrmm of ^^P-lmbel#d proteins in 
whole cell homogenmte of cultured myoblasts. 
Lane (1) coomassie blue-stain of proteins in the 
cell homogenate; (2) no additions; lane (3) 1.0 
mN MIB6; lane (4) 5.0 nM DTT; lane (5) 200 mM 
sodium phosphate. Conditions are as described in 
"Materials and Methods.'* Lanes 2-5 are 
autoradiograns 
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Inhibition of total labeling of proteins, determined by the 
filter paper assay, in the presence of NIB6 was observed. 
Interference of MIB6 with ^ P^(ADP-ribose) transfer to 
endogenous proteins, however, was not seen on SDS-PA6E 
(Figure 9, lane 3). 
Because DTT was shown to inhibit endogenous ADP-
ribosyltransferases (36) in skeletal muscle membranes, we 
studied the effect of DTT on the labeling of endogenous 
proteins in homogenized myoblasts by endogenous ADP-
ribosyltransferase. In the presence of DTT, labeling of the 
42,000 dalton band was inhibited (Figure 9, lane 4). A 
possibility exists that this effect is also due to the 
inhibition of a transferase present in the myoblasts. 
The effect of inorganic phosphate on the labeling of 
endogenous proteins was also investigated since high 
concentrations of inorganic phosphate has been shown to 
regulate the enzymatic activity of certain endogenous ADP-
ribosyltransferases (37). In the presence of 200 mM 
phosphate, a decrease in the total amount of labeling was 
observed and labeling of only two bands, 42,000 and 36,000 
daltons, was seen (Figure 9, lane 5). A decrease in 
labeling of these two bands was also observed in presence of 
inorganic phosphate. 
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The whole cell honogenate was fractionated and proteins 
In each fraction were labeled with to see which 
fractlon(s) contains the two major labeled protein bands 
(Figure 10). The protein band with Mr 36,000 Is 
predominantly labeled In the 100,000xg supernatant and some 
labeling of this band was also observed In the nuclear 
pellet and In the 100,000xg pellet. The 42,000 dalton band 
Is present In all three fractions and, again, labeling of 
this band Is Inhibited by DTT. These results suggest that 
the two protein bands, 42,000 and 36,000 dalton, may be of 
further Interest In Identification of substrates for 
endogenous ADP-rlbosyltransferases found in primary chick 
myoblasts. 
Figura 10. An autoradiegraa of protein# in 
various fractions. Lanes (l), (2), and 
(3) are coomassie blue-stains of proteins in 
the nuclear, 100,000xg supernatant, and 
lOOfOOOxg pellet, respectively. Lane (4) 
nuclear pellet; lane (5) nuclear pellet + DTT; 
lane (6) 100,000xg supernatant; (7) 100,000xg 
supernatant + DTT; lane (8) 100,000xg pellet; 
lane (9) 100,000xg pellet + DTT; and 
Conditions are as described in "Materials and 
Methods." Lanes 4-9 are autoradiograns 
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Myogenic cell differentiation during embryonic 
development Is well understood, although the biochemical 
regulation of this process remains to be completely 
elucidated. Terminal differentiation of embryonic precursor 
cells to form muscle fibers Involves the withdrawal of 
myoblasts from the cell cycle, fusion of postmitotic 
myoblasts to form myotubes, and expression of muscle-
specif Ic forms of enzymes and contractile proteins. 
Conversion of proliferating myogenic precursor cells to 
postmitotic myoblasts Involves the expression of specific 
myogenic determination genes, several of which have been 
recently Identified, Including myd (38), Myo D1 (39), 
myogenln (40), Myf5 (41), and herculln (42). Each has been 
shown to be capable of Initiating myogenesls In cultured 
fibroblasts by transfectlon. The sequence of activation and 
the regulation of expression of these genes are the objects 
of substantial current research. Both proliferation and 
differentiation of myogenic cells are controlled, both 
positively and negatively, by regulatory growth factors 
(43,44). The biochemical signalling mechanisms Involved In 
the regulation of myogenesls by growth factors are not 
understood. 
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Our studies indicate that arginine-specific mono(ADP-
ribosyl)transferase may play some role in myogenesis. Both 
arginine-specific ADP-ribosyltransferase and ADP-
rlbosylarginine hydrolase activities were detected in 
primary chick myoblasts. We have shown that MIB6 reversibly 
inhibits fusion, differentiation-specific increase in PCK 
activity, both DNA and protein accumulation, expression of 
muscle-specific protein, titin, decreases the total NAD 
levels, and also decreases the activity of an arginine-
specific mono(ADP-ribosyl)transferase. This is the first 
study in which a specific inhibitor for an endogenous 
arginine-specific mono(ADP-ribosyl)transferase has been used 
in myoblast cultures. 
The results presented in this paper suggest that MIB6 
blocks the differentiation of myoblasts, not just the fusion 
event itself, as expression of muscle-specific proteins have 
been reported in cultures in which fusion, but not the 
entire differentiation process, was blocked. Blockage of 
DNA accumulation by MIB6 suggests that MIBG blocks myoblast 
proliferation as well. 
Presence of MIBG in myoblast cultures also resulted in 
lower levels of NAD in comparison to the untreated cultures. 
Jacobson and Jacobson (31) have shown that NAD levels appear 
to be significantly lower in dividing cells than in 
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non-dividing cells and that this increase in NAD levels is 
correlated with the cessation of DNA synthesis. Our results 
are consistent with their results in that MIB6 inhibits DNA 
accumulation, suggesting that cells stop dividing, and hence 
lower levels of NAD are observed. The mechanism that 
regulate the levels of NAD within cells are not well 
understood. ADP-ribosylated NIB6 in cultures treated with 
MIB6 could not be detected by the HPLC method due possibly 
to the presence of low levels of MIB6 in the cultures. 
We have shown that norepinephrine and meta-
iodobenzylamine do not have any effect on primary chick 
myoblasts. These results suggest that the guanidino group 
of MIBG may play an important role in the observed effects 
of MIBG on cultured myoblasts. Use of M6B6 provided 
additional evidence to support this hypothesis. Low 
concentrations of M6B6 did not have any effect on myoblasts, 
whereas, higher concentration of N6B6 inhibited fusion. 
This result is consistent with the fact that higher 
concentration of M6B6 is needed to inhibit the endogenous 
ADP-ribosyltransferase. If the observed effects of MIBG are 
due to involvement of the guanidino group in a process other 
than ADP-ribosylation, then lower concentration of MGBG 
should have had some effect on myoblast cultures. The 
results presented here suggest a role for arginine-specific 
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mono(ADP-ribosyl)ation reactions In the regulation of 
myogenic cell differentiation. The two protein bands, 
36,000 Da and 42,000 Da, are of further Interest In studying 
the role of arglnlne-speclflc mono(ADP-rlbosyl)tlon 
reactions In myoblast cultures. 
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GENERAL SUMMARY 
ADP-rlbosylatlon is a recently discovered post-
.translational modification that is ubiquitous in nature. 
Both poly- and mono(ADP-ribosyl)ation reactions play an 
important role in biological systems. Poly(ADP-
ribosyl)ation reactions are well studied and are generally 
involved in DNA repair and cellular differentiation (1). 
Mono(ADP-ribosyl)ation reactions are catalyzed by both 
prokaryotic and and eukarytic ADP-ribosyltransferases. 
Bacterial mono(ADP-ribosyl)transferases are well 
characterized and their functions are well established. 
Eukaryotic ADP-ribosyltransferases, found in a variety of 
animal tissues (24-31), are partially purified and 
characterized but, the functions of these eukaryotic ADP-
ribosyl transferases are not known. 
This dissertation described the study of arginine-
specific mono(ADP-ribosyl)ation reactions. The function 
and structure of most of the bacterial mono(ADP-
ribosyl) transferases is known, but the specificity 
requirements for transferases remain unknown. 
Cholera toxin, an arginine-specific mono(ADP-
ribosyl) transferase was used to gain some understanding of 
the factors influencing the specificity of these reactions. 
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The target proteins for cholera toxin are the hetero-
trimeric GTP-binding proteins in eukaryotic systems (19,44). 
ADP-ribosylation of these proteins alters their function. 
Cholera toxin also ADP-ribosylates a number other 
unidentified proteins in vitro (19). What is the basis of 
selectivity of these substrates by cholera toxin? 
Studies with low-molecular-weight compounds indicate 
that a negatively charged group near an arginyl residue 
somehow decreases the extent of ADP-ribosylation while a 
hydrophobic environment around the ADP-ribosylation site 
seems to increase the extent of ADP-ribosylation by cholera 
toxin. A similar observation was made from our studies with 
synthetic peptides. Peptide with a charged amino acid near 
an ADP-ribosylation site was not a very good substrate for 
cholera toxin. A peptide with a more hydrophobic 
environment around the arginyl residue was a much better 
substrate. The best substrate was kemptide, Leu-Arg-Arg-
Ala-Ser-Leu-Gly. A positive charge around an ADP-
ribosylation site may also be important. 
Kemptide, a synthetic peptide whose sequence is found 
in pyruvate kinase, was used further to investigate the 
relationship between ADP-ribosylation and phosphorylation. 
Tanigawa et al. have reported that ADP-ribosylation of 
histones (7) and phosphorylase kinase (8) by hen liver 
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nuclei ADP-ribosyltransferase suppresses subsequent 
phosphorylation by cAMP-dependent protein kinase. Similar 
observations were made in our model system where kemptide 
was used as a substrate for both cholera toxin and cAMP-
dependent protein kinase. ADP-ribosylation of the arginyl 
residues suppressed subsequent phosphorylation by cAMP-
dependent protein kinase and phosphorylation of the seryl 
residue decreased the extent of ADP-ribosylation by cholera 
toxin. These results are consistent with the fact that 
arginyl residues on the N-terminus of the phosphorylatable 
seryl residue are important for phosphorylation by cAMP-
dependent protein kinase and that negatively charged group 
near an ADP-ribosylation site decreases the extent of ADP-
ribosylation. This type of regulation is possible in 
proteins in vivo since the protein substrates for cAMP 
dependent protein kinase contain arginyl residues near the 
phosphorylatable seryl residue. These arginyl residues are 
potential sites for ADP-ribosylation. It would be very 
interesting to see which arginyl residue(s) in histones 
is/are ADP-ribosyl'ated by the hen liver nuclei and whether 
this arginyl residue(s) is/are near a phosphorylation site. 
Further study of the specificity requirements for 
cholera toxin, using synthetic peptides containing the 
sequences present in Ta, Gsa, Gia, and Goa, revealed little 
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information. The proteins. Ta and Gsa, are ADP-ribosylated 
by cholera toxin in vivo (19,32). Proteins, Gia and Goa, 
are not substrates for cholera toxin (92). All peptides 
were ADP-ribosylated by cholera toxin approximately to the 
same extent and greater specificity toward the second 
arginyl residue was observed in peptides derived from Gia 
and Goa. An ADP-ribosylation factor, ARF, did not induce 
specificity that is observed in intact proteins. These 
results suggest that a factor other than the amino acids 
surrounding the ADP-ribosylation site is involved in 
determining the specificity that is seen in intact proteins. 
The structure of the intact protein and/or the 
structure of the region surrounding the ADP-ribosylation 
site may be an important factor in determining the 
specificity with which cholera toxin ADP-ribosylates certain 
GTP-binding proteins. The cellular environment surrounding 
the protein or interaction of some protein component may 
also be important. Use of longer peptides with some 
structure may provide some understanding of the specificity 
of cholera toxin-catalyzed ADP-ribosylation reactions. 
The physiological roles of the cellular mono(ADP-
ribosyl)transferases have not definitely been established. 
At present it seems reasonable to suspect that activation of 
adenylate cyclase (3), regulation of protein biosynthesis at 
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the level of EF-2 (2), and ion transport (4) involve 
mono(ADP-ribosyl)transferases. 
Evidence for the involvement of cellular ADP-
ribosyltransferases in adenylate cyclase regulation was 
first provided by the findings of Moss and Vaughan that 
transferase A from turkey erythrocytes stimulates adenylate 
cyclase from bovine brain (25). Diphthamide, modification 
site for diphtheria toxin and the cellular ADP-
ribosyl transferase characterized by Iglewski et al. (27), 
has been conserved throughout eukaryotic evolution. It is 
reasonable to expect that under normal conditions, the 
eukaryotic ADP-ribosyltransferase may catalyze the ADP-
ribosylation of EF-2 and thereby controlling protein 
synthesis. 
ADP-ribosylation may also control transport of certain 
ions across biological membranes. ADP-ribosylation of 
proteins in renal brush border membranes is paralleled by 
inhibition of Pi transport (93). There is some evidence 
that Ca2+ release from rat liver mitochondria is stimulated 
by ADP-ribosylation of a protein located in the inner 
mitochondrial membrane(4). Finally, studies by Tanigawa et 
al. (7) and Tsuchiya et al. (8) showing suppression of 
phosphoryation by ADP-ribosylation suggest some regulatory 
role of certain proteins for ADP-ribosyltransferases. 
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The effects produced by the general ADP-ribsylation 
inhibitor, 3-ABA, on myoblast cultures could be due to 
either poly or mono(ADP-ribosyl)ation reactions (1). Shall 
and coworkers (1) used high concentrations (8 mM) of this 
inhibitor and higher concentrations of 3-ABA have been shown 
to inhibit mono(ADP-ribosyl)transferases. We have shown 
similar effects on myoblast cultures with meta-
iodobenzylguanidine, an inhibitor of arginine-specific 
endogenous mono(ADP-ribosyl)transferases. It not only 
reversibly blocked fusion and differentiation-specific 
increase in PCK activity, but also reversibly blocked DNA 
and protein accumulation and expression of muscle-specific 
protein, titin. The mechanism by which NIB6 elicits these 
effects, however, is not clear. It seems that the guanidine 
group of MIBG may be Involved. The results presented, 
however, do suggest a role for arginine-specific mono(ADP-
ribosyl) ation reactions in myogenesis. 
Further experiments with this system are needed in 
order to establish the role of the transferase in 
myogenesis. Cultured myoblasts seem to be a good system in 
which to study the role of mono(ADP-ribosyl)reactions since 
both ADP-ribosylhydrolase and ADP-ribosyltransferase has 
been detected. Identification of protein substrates for 
these mono(ADP-ribosyl)transferases and defined systems 
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containing purified enzymes and substrates are required to 
fully understand the significance of the cellular ADP-
ribosyltransferases. 
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